US20160022303A1 - Lead removal sleeve - Google Patents

Lead removal sleeve Download PDF

Info

Publication number
US20160022303A1
US20160022303A1 US14/877,683 US201514877683A US2016022303A1 US 20160022303 A1 US20160022303 A1 US 20160022303A1 US 201514877683 A US201514877683 A US 201514877683A US 2016022303 A1 US2016022303 A1 US 2016022303A1
Authority
US
United States
Prior art keywords
lead
tissue
sleeve
tissue growth
removal sleeve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/877,683
Inventor
Richard Fiser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spectranetics LLC
Original Assignee
Spectranetics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectranetics LLC filed Critical Spectranetics LLC
Priority to US14/877,683 priority Critical patent/US20160022303A1/en
Assigned to MIDCAP FINANCIAL TRUST, AS AGENT reassignment MIDCAP FINANCIAL TRUST, AS AGENT SECURITY INTEREST (REVOLVER) Assignors: THE SPECTRANETICS CORPORATION
Assigned to MIDCAP FINANCIAL TRUST, AS AGENT reassignment MIDCAP FINANCIAL TRUST, AS AGENT SECURITY INTEREST (TERM) Assignors: THE SPECTRANETICS CORPORATION
Publication of US20160022303A1 publication Critical patent/US20160022303A1/en
Assigned to THE SPECTRANETICS CORPORATION reassignment THE SPECTRANETICS CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FISER, RICHARD LOFTON
Assigned to ANGIOSCORE INC., THE SPECTRANETICS CORPORATION reassignment ANGIOSCORE INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: MIDCAP FINANCIAL TRUST
Assigned to ANGIOSCORE INC., THE SPECTRANETICS CORPORATION reassignment ANGIOSCORE INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: MIDCAP FINANCIAL TRUST
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/3207Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
    • A61B17/32075Pullback cutting; combined forward and pullback cutting, e.g. with cutters at both sides of the plaque
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3203Fluid jet cutting instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3203Fluid jet cutting instruments
    • A61B17/32037Fluid jet cutting instruments for removing obstructions from inner organs or blood vessels, e.g. for atherectomy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/3207Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/3207Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
    • A61B17/320725Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3209Incision instruments
    • A61B17/3211Surgical scalpels, knives; Accessories therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/50Instruments, other than pincettes or toothpicks, for removing foreign bodies from the human body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/24Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
    • A61B18/245Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter for removing obstructions in blood vessels or calculi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/02Devices for expanding tissue, e.g. skin tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • A61N1/057Anchoring means; Means for fixing the head inside the heart
    • GPHYSICS
    • G10MUSICAL INSTRUMENTS; ACOUSTICS
    • G10LSPEECH ANALYSIS OR SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING; SPEECH OR AUDIO CODING OR DECODING
    • G10L21/00Processing of the speech or voice signal to produce another audible or non-audible signal, e.g. visual or tactile, in order to modify its quality or its intelligibility
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04LTRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L65/00Network arrangements, protocols or services for supporting real-time applications in data packet communication
    • H04L65/40Support for services or applications
    • H04L65/403Arrangements for multi-party communication, e.g. for conferences
    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04MTELEPHONIC COMMUNICATION
    • H04M3/00Automatic or semi-automatic exchanges
    • H04M3/42Systems providing special services or facilities to subscribers
    • H04M3/56Arrangements for connecting several subscribers to a common circuit, i.e. affording conference facilities
    • H04M3/568Arrangements for connecting several subscribers to a common circuit, i.e. affording conference facilities audio processing specific to telephonic conferencing, e.g. spatial distribution, mixing of participants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B2017/320004Surgical cutting instruments abrasive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B2017/320044Blunt dissectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • A61N1/057Anchoring means; Means for fixing the head inside the heart
    • A61N2001/0578Anchoring means; Means for fixing the head inside the heart having means for removal or extraction
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04CROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
    • F04C2270/00Control; Monitoring or safety arrangements
    • F04C2270/04Force
    • F04C2270/041Controlled or regulated

Definitions

  • Laser devices typically employ laser energy to cut the scar tissue away from the lead thus allowing for removal. Examples of such laser devices and systems are described and illustrated in U.S. Pat. Nos. 5,383,199 and 5,824,026 and 5,916,210 and 6,228,076 and 6,290,668 all of which are hereby incorporated herein by reference in their entirety for all that they teach and for all purposes.
  • a traditional approach to removing tissue from implanted leads is based on the presumption that the tissue growths are adhered directly to the surfaces of the implanted leads. As such, methods and systems have been designed to dislocate the connection between the tissue attached to the implanted device and the body of a patient. Although some tissue may remain on the lead, current methods focus on removing most of the tissue surrounding a circumference of the lead. In other words, while tissue may remain attached around the lead, current systems essentially core around this tissue surrounding the circumference of a lead to free the lead along with a section of the cored tissue to create slack for removing the lead from a patient.
  • the tissue growth may constrict a lead, especially if a force is applied to one end of the lead during a removal operation.
  • the tissue growth may capture the lead and prevent removal, by, among other things, being attached to the patient and the lead simultaneously. Additionally or alternatively, the tissue growth, during attempted lead removal, may at least partially adhere to the lead in one or more sections while completely forming around the lead.
  • the lead may be able to be removed without mechanically removing or laser ablating the entire tissue region surrounding the lead in a 360 degree, or circumferential, fashion. Rather, at least a portion of the tissue surrounding the lead may be dilated to reduce and/or eliminate forces preventing movement of the lead within a patient.
  • a lead removal sleeve, or structure may be introduced over a lead and worked into an area between the tissue growth and the lead. The structure may be configured to dilate at least a portion of the tissue surrounding the lead. Additionally, the structure may be configured to provide support and/or clearance around a section of the lead.
  • the support may maintain the tissue growth in a dilated state around a section of the lead, while the clearance may facilitate at least partially unrestricted movement and even subsequent removal of the lead from the patient.
  • the structure may include one or more features to control the support provided and/or the structure clearance for lead movement (e.g., ribs, various thicknesses, collapsing sections/points, coatings, films, jackets, and the like).
  • a device, method and/or system such as a device that includes a sleeve having an outer surface, a distal end, a proximal end, and an inner lumen running from the proximal to the distal end, wherein the sleeve facilitates the dilation of formed tissue surrounding a lead, and optionally a method and system capable of removing the lead from the formed tissue and/or sleeve that captures at least a portion of an implanted lead.
  • a lead removal method comprising: engaging a lead removal apparatus over an implanted object in a patient; passively dilating a length of tissue growth surrounding the implanted object; and thereafter removing the implanted object from the tissue growth.
  • the passively dilating and thereafter removing steps may comprise the sub-steps: attaching a mechanical traction device to the implanted object; inserting the mechanical traction device into the lead removal apparatus, the lead removal apparatus further comprising: a flexible shaft, wherein the flexible shaft has a proximal and a distal end; an internal lumen, wherein the internal lumen is configured to allow at least one of an implanted object and mechanical traction device to pass therethrough; and a tissue dilating tip operatively connected to the distal end of the flexible shaft; applying a mechanical traction force to the mechanical fraction device; indexing the lead removal apparatus to an engagement area of the tissue growth in contact with the implanted object; and moving the tissue dilating tip into the tissue growth, such that the tissue growth is dilated around the flexible shaft and dislocated from the implanted object at least at the engagement area with the tissue dilating tip.
  • a system to remove a lead from a vascular lumen comprising: a lead locking device for locking onto a lead within the vascular lumen; a flexible shaft comprising: a proximal end; a distal end comprising a tip capable of passively dilating and directing tissue about a lead; and an internal lumen configured to allow at least one lead to pass therethrough, wherein the lead locking device holds the lead while the tip dilates tissue surrounding at least a portion of the lead.
  • the method can include the steps of inserting a lead removal sleeve in an area between an implanted object and at least a portion of a tissue growth at least substantially surrounding the implanted object in a patient and thereafter removing the implanted object.
  • the lead removal sleeve can be inserted along an entire length of a tissue growth in an area between an implanted object and the tissue growth. In some cases, the lead removal sleeve may be inserted along only a partial length, not an entire length, of a tissue growth in an area between the implanted object and the tissue growth.
  • the lead removal sleeve may be manufactured as an extruded shape of substantially uniform cross-sectional area. Additionally or alternatively, the distal and or proximal end of the lead removal sleeve may be shaped to include a surface and/or geometry other than the substantially uniform cross-sectional area.
  • the lead removal sleeve may include a tissue dislocation, or dilation, tip disposed at or adjacent to the distal end of the sleeve.
  • the tissue dislocation tip may be configured to contact and direct at least a portion of tissue growth away from contacting a surface of an implanted lead.
  • the tissue dislocation tip may be configured to wedge into an area between the tissue growth and an implanted lead.
  • the tissue may be caused to dilate about an outer surface of the lead removal sleeve.
  • the tissue dislocation tip may be configured to “passively” wedge into the area between the tissue growth and the implanted lead, that is, without substantially cutting or disrupting the formation of the tissue growth.
  • the tissue dislocation tip may include one or more of various shapes, thicknesses, hardnesses, materials, and the like.
  • Removal of the implanted lead from the formed tissue, or tissue growth may be effected by creating clearance between the lead and the tissue growth.
  • tissue By dilating the formed tissue along an axial portion, or length, of the tissue in contact with the surgically implanted device or surgical implant, it is anticipated that the tissue may stretch around at least a portion of the outer surface of the lead removal sleeve.
  • the outer surface of the lead removal sleeve acts to support the tissue growth in a dilated state.
  • the lead may move within the inner lumen of the lead removal sleeve without being subjected to any constriction forces subjected by the tissue growth.
  • the lead removal sleeve includes a flexible shaft having a proximal end, a distal end, and an internal lumen having an internal diameter configured to allow a lead, lead locking device, and/or other implanted device to pass through it.
  • the sleeve may also include a tissue dislocation tip operatively coupled with the distal end of the flexible shaft.
  • the dislocation and/or dilation of formed tissue can be performed by at least one of moving, directing, displacing, dilating, expanding, wedging, and combinations thereof. It is anticipated that the lead removal sleeve may be oriented within a patient via use of the flexible shaft and monitor, or a catheter-based system. In some cases, the lead removal sleeve may be positioned over an implanted lead, such that the tissue dislocation tip is caused to contact tissue growth in contact with the lead.
  • Bioresorbable may be used herein to refer to the property of a material manufactured to degrade, biodegrade, bioabsorb, dissolve, and/or be absorbed by a body.
  • Bioresorbable materials may include, but are in no way limited to, iron, magnesium, metals, alloys thereof, polymers, amino-acid based polymers, polyester amides, silica composites, coatings, and combinations thereof.
  • Bioresorbable materials may be controlled to degrade over a period of time by incorporating layers of materials and/or coatings in specific combinations. Such combinations may include constructing various material layers, including coatings, with known degradation rates in an order that may facilitate degradation over a designed time period.
  • a “lead” is a conductive structure, typically an electrically insulated coiled wire.
  • the electrically conductive material can be any conductive material, with metals and intermetallic alloys common.
  • the outer sheath of insulative material is biocompatible and biostable (e.g., non-dissolving in the body) and generally includes organic materials such as ultra high weight polyethylene, polyurethane, and polyimide.
  • Lead types include, by way of non-limiting example, epicardial and endocardial leads. Leads are commonly implanted into a body percutaneously or surgically.
  • FIG. 5B shows a cross-sectional view of an area of vasculature with a lead removal sleeve engaging and dilating formed tissue surrounding an implanted lead in accordance with embodiments of the present disclosure
  • FIG. 5D shows a cross-sectional view of an area of vasculature with an implanted lead subjected to a removal force within an area of a lead removal sleeve dilating formed tissue along an entire length of the formed tissue in accordance with embodiments of the present disclosure
  • FIG. 5E shows a cross-sectional view of an area of vasculature with a lead removal sleeve in a tissue growth after a lead has been removed from the area in accordance with embodiments of the present disclosure
  • FIG. 5F shows a cross-sectional view of an area of vasculature with a lead removal sleeve within an area of a tissue growth where the sleeve is subjected to removal forces in accordance with embodiments of the present disclosure
  • tissue displacing tip or “tissue dilating tip” are used in this disclosure, it is not limited to an extruded shape of uniform cross-section. These phrases are further intended to encompass any modality for dilating or displacing tissue, including the various modalities discussed herein. Nonlimiting examples include not only a tapered area, point, or shaped end disposed at or near the distal end of the sleeve, but also a machined tip, formed tip, welded and/or tip otherwise connected to the flexible shaft of the lead removal sleeve.
  • FIG. 2B a detail section view of a patient vasculature and implanted lead 104 subjected to a traction force 120 in second path in accordance with some embodiments of the present disclosure is shown.
  • at least one end of the lead 104 may be directed inside a patient 102 for removal via a path within the vasculature.
  • Direction of the lead 104 may be effected via a snaring tool, lead-locking device, traction device, combinations thereof, and the like.
  • the lead 104 is directed toward the general direction of a patient's femoral artery via the inferior vena cava.
  • FIG. 2C shows a detail section view of a patient vasculature and implanted lead 104 subjected to a traction force 120 in third path in accordance with some embodiments of the present disclosure. Similar to FIGS. 2A and 2B , the lead 104 may be directed along a path in the patient vasculature. In this case, the lead 104 may be directed toward the general direction of a patient's jugular vein.
  • FIG. 4 shows a cross-sectional view of the curved area of vasculature of FIG. 3 taken along line A-A.
  • reference may be made to the tissue growth 108 forming a tube 132 (or cylindrical or sock-like structure) around the implanted lead 104 .
  • Previous methods have been disclosed that are directed to separating the tissue around the lead 104 in the area defined by the tube 132 .
  • this thin wall may include a thickness range from 0.005′′ to 0.1875.′′
  • the thickness may vary at the tissue dislocation tip 508 , such that a thickness at the tip 508 is less than a thickness along another portion of the lead removal sleeve 504 proximal to the tissue dislocation tip 508 . This variation in thickness may act to wedge the tissue dislocation tip 508 into the area between the tissue growth 108 and the lead 104 . Depending on the tissue growth 108 , various thicknesses may be required to work into an area between the tissue growth 108 and the lead 104 .
  • Tougher tissue growths 108 may require a thinner wall thickness of the lead removal sleeve 504 , while softer tissue growths 108 may allow for a greater wall thickness of the lead removal sleeve 504 .
  • the lead removal sleeve 504 and/or its constituent parts, may be manufactured from any plastic, metal, resin, composite material, and/or combinations thereof disclosed herein.
  • the lead removal sleeve 504 may be manufactured from the same material as the inner lumen 510 and vice versa.
  • the lead removal sleeve 504 may be manufactured as a single extruded piece, as a tri-coil assembly, and even as a combination of various components.
  • FIG. 5B shows a cross-sectional view of an area of vasculature with a lead removal sleeve 504 engaging formed tissue 108 in accordance with embodiments of the present disclosure.
  • the lead removal sleeve 504 may be pushed, indexed, and/or gradually rotated into the formed tissue 108 .
  • the directional force 518 may be applied to the lead removal sleeve 504 via one or more mechanical actuators, electrical actuators, manual positioning, and combinations thereof.
  • the tissue dislocation tip 506 may dilate the tissue growth 108 by dislocating, expanding, stretching, parting, and/or otherwise causing a separation of tissue 520 at the engagement area 516 .
  • the separation of tissue 520 redirects forces (e.g., clamping, constricting, compression, etc.) subjected to the lead 104 by the tissue growth 108 to be directed to an outer surface associated with the flexible shaft 506 .
  • FIG. 5E shows a cross-sectional view of an area of vasculature with a lead removal sleeve 504 in a tissue growth 108 after a lead 104 has been removed in accordance with embodiments of the present disclosure.
  • the lead removal sleeve 504 may continue to dilate the tissue growth 108 even after a lead 104 has been removed.
  • the lead removal sleeve 504 may be configured and/or allowed to remain inside the vasculature of a patient 102 .
  • the lead removal sleeve 504 may be manufactured from or include at least one bioresorbable material.
  • FIG. 5F shows a cross-sectional view of an area of vasculature with a lead removal sleeve 504 within an area of a tissue growth 108 where the sleeve 504 is subjected to removal forces in accordance with embodiments of the present disclosure.
  • the lead removal sleeve 504 may be pulled from a tissue growth 108 in a removal direction 526 .
  • one or more forces subjected to an outer diameter of the sleeve 504 may cause the sleeve 504 to radially collapse.
  • the method 600 starts at 604 and begins by connecting a lead-locking device or other traction device to the lead 104 (step 608 ).
  • the lead-locking device may be inserted into the core of an implanted lead 104 .
  • a traction device may be connected to the lead 104 to provide traction on the lead 104 .
  • mechanical traction can be achieved in leads 104 by inserting a locking stylet into the lead 104 and applying a pull force onto the lead 104 via the locking stylet.
  • the lead removal sleeve 504 may be inserted into a support catheter.
  • the support catheter may be inserted adjacent to the tissue growth 108 and may be configured to at least partially contain and/or restrain movement associated with the lead removal sleeve 504 .
  • the support catheter may include a vacuum system that may be configured to direct a vacuum force to an outer diameter of the lead removal sleeve 504 .
  • the vacuum system may be selectively operated to allow free movement and/or restrict movement based on an unapplied vacuum and an applied vacuum, respectively.
  • the vacuum may be contained adjacent to an inner diameter of the support catheter.
  • Indexing the sleeve 504 along the lead 104 and into a tissue growth 108 may require a rotational movement of the sleeve 504 about an axis running from the proximal to the distal end of the sleeve 504 .
  • the lead removal sleeve 504 may be worked into an area between the tissue growth 108 and the lead 104 by rotating and translating the sleeve 504 .
  • the device(s) may be electrical, mechanical, electro-mechanical, and/or combinations thereof.

Abstract

Methods and systems for removing an object, such as a lead, from formed tissue are provided. Specifically, a lead removal sleeve is configured to engage patient formed tissue at a dilation engagement point. The lead removal sleeve is configured to dilate the formed tissue around a lead, while providing an inner lumen with clearance for the lead to move within the sleeve. It is an object of the lead removal sleeve to support the formed tissue, and even forces of the formed tissue, with a structure of the sleeve as the lead is removed from a patient. The methods and systems are well suited for use in cardiac pacing or defibrillator lead explant procedures.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • The present application claims the benefit of and priority, under 35 U.S.C. §119(e), to U.S. Provisional Application Ser. No. 61/701,520, filed Sep. 14, 2012, entitled “TISSUE SEPARATING METHODS AND SYSTEMS,” which is hereby incorporated herein by reference in its entirety for all that it teaches and for all purposes.
  • This application is also related to U.S. patent application Ser. Nos. ______/______,______, filed on Mar. 14, 2013, entitled, “Tissue Slitting Methods and Systems” (Attorney Docket No. 6593-208); ______/______,______, filed on Mar. 14, 2013, entitled, “Tissue Slitting Methods and Systems” (Attorney Docket No. 6593-251); ______/______,______, filed on Mar. 14, 2013, entitled, “Tissue Slitting Methods and Systems” (Attorney Docket No. 6593-252); ______/______,______, filed on Mar. 14, 2013, entitled, “Tissue Slitting Methods and Systems” (Attorney Docket No. 6593-253); and ______/______,______, filed on Mar. 14, 2013, entitled, “Expandable Lead Jacket” (Attorney Docket No. 6593-246). The entire disclosures of the applications listed above are hereby incorporated herein by reference, in their entirety, for all that they teach and for all purposes.
  • FIELD OF THE DISCLOSURE
  • The present disclosure relates generally to devices, methods and systems for removing an implanted object from a patient, and more specifically, to techniques for removing an electrical lead from tissue attached to a patient.
  • BACKGROUND
  • Cardiac pacing systems typically include a pacemaker and one or more leads, which are placed inside the body of a patient. The pacemaker includes a power source and circuitry configured to send timed electrical pulses to the lead. The lead carries the electrical pulse to the heart to initiate a heartbeat, and transmits information about the heart's electrical activity to the pacemaker. The lead can include a fixation mechanism that holds the lead to the cardiac tissue. In some cases, a lead is inserted through a vein or artery (collectively vasculature) and guided to the heart where it is attached. In other instances, a lead is attached to the outside of the heart. During its time in the body, tissue can attach to the lead in the form of lesions, adhesions or scar tissue, or tissue can encase a lead. In addition, the lead and/or tissue can become attached to the vasculature wall. At times, leads may be removed from patients for numerous reasons, including but not limited to, infections, lead age, and lead malfunction. Accordingly, removal or extraction of the lead may present associated complications.
  • Current lead extraction techniques include mechanical traction, mechanical devices, and laser devices. Mechanical traction can be accomplished by inserting a locking stylet into the hollow portion of the lead and then pulling the lead to remove it. An example of such a lead locking device is described and illustrated in U.S. Pat. No. 6,167,315 to Coe et al., which is hereby incorporated herein by reference in its entirety for all that it teaches and for all purposes. In some cases, dilating telescopic sheaths may also be used to strip away the scar tissue adhering the lead to the body. Examples of a such devices and methods used to extract leads is described and illustrated in United States Patent Publication No. 2008/0154293 to Taylor, which is hereby incorporated herein by reference in its entirety for all that it teaches and for all purposes.
  • Dilation techniques typically involve pushing tissue away from the lead when the sheath is pushed longitudinally along the lead. However, this pushing technique may be difficult to implement, particularly when the lead has a tortuous path or curvature because the requisite longitudinal forces to extract the tissue from the lead in under these circumstances increase. The longitudinal forces also may require heavy counter forces on the lead, which may result in lead breakage.
  • Some mechanical sheaths have proposed trigger mechanisms for extending a blade from a sheath. At least some of these devices, however, involve complicated activation mechanisms and may not be well suited for negotiating the tortuous paths that exist in certain vascular or physiological environments.
  • Laser devices typically employ laser energy to cut the scar tissue away from the lead thus allowing for removal. Examples of such laser devices and systems are described and illustrated in U.S. Pat. Nos. 5,383,199 and 5,824,026 and 5,916,210 and 6,228,076 and 6,290,668 all of which are hereby incorporated herein by reference in their entirety for all that they teach and for all purposes.
  • Further complicating lead removal is the fact that in some cases, the leads may be located in, and/or attached to, the body of a patient in a structurally-weak portion of the vasculature. For instance, typical leads in a human may pass through the innominate vein, past the superior vena cava (“SVC”), and into the right atrium of the heart. A majority of tissue growth can occur along the SVC and other locations along the innominate vein where the leads make contact with the vein walls. However, tissue growth can also occur at locations within a patient where the leads make contact with arterials or other areas of the vasculature. Certain veins and arteries, and certain areas of vein and arterial walls, can be thin which can make lead removal a complicated and delicate process.
  • SUMMARY
  • A traditional approach to removing tissue from implanted leads is based on the presumption that the tissue growths are adhered directly to the surfaces of the implanted leads. As such, methods and systems have been designed to dislocate the connection between the tissue attached to the implanted device and the body of a patient. Although some tissue may remain on the lead, current methods focus on removing most of the tissue surrounding a circumference of the lead. In other words, while tissue may remain attached around the lead, current systems essentially core around this tissue surrounding the circumference of a lead to free the lead along with a section of the cored tissue to create slack for removing the lead from a patient.
  • Surprisingly and unexpectedly, it has been discovered that tissue growth may not adhere directly to the implanted lead but actually form a substantially cylindrical “tube” around the implanted substantially cylindrical lead at a given contact area. Contrary to conventional wisdom, the tissue growth typically does not physically adhere to the lead. For example, this tissue growth, once formed completely around a lead, forms a tubular-shaped member that essentially holds the lead and resists lead removal. The tubular-shaped section of formed tissue around an implanted device may impart a combination of connection forces/modes that prevent the removal of the device from a patient. For example, the tubular-shaped section of formed tissue, or tissue growth, may constrict, capture, and/or surround implanted leads. In some cases, the tissue growth may constrict a lead, especially if a force is applied to one end of the lead during a removal operation. In other cases, the tissue growth may capture the lead and prevent removal, by, among other things, being attached to the patient and the lead simultaneously. Additionally or alternatively, the tissue growth, during attempted lead removal, may at least partially adhere to the lead in one or more sections while completely forming around the lead.
  • Based upon the surprising and unexpected discovery that tissue growth may not be directly adhered to the implanted lead, alternative devices and methods may be used to extract an object from such tissue. In other words, methods and devices are disclosed herein, that are capable of exploiting the growth nature of the tissue around a lead to efficiently extract the lead from tissue that acts to hold the lead with some type of force. The tissue growth may form around the lead such that the lead is contained from free movement within a patient. For instance, the tissue growth may impart a clamping, or constrictive, force around the circumference of the lead that can prevent movement of the lead within this constrictive tissue growth. Due to the taught and constrictive nature of the tissue around the lead, the lead may be able to be removed without mechanically removing or laser ablating the entire tissue region surrounding the lead in a 360 degree, or circumferential, fashion. Rather, at least a portion of the tissue surrounding the lead may be dilated to reduce and/or eliminate forces preventing movement of the lead within a patient. In some cases, a lead removal sleeve, or structure, may be introduced over a lead and worked into an area between the tissue growth and the lead. The structure may be configured to dilate at least a portion of the tissue surrounding the lead. Additionally, the structure may be configured to provide support and/or clearance around a section of the lead. As can be appreciated, the support may maintain the tissue growth in a dilated state around a section of the lead, while the clearance may facilitate at least partially unrestricted movement and even subsequent removal of the lead from the patient. It is anticipated that the structure may include one or more features to control the support provided and/or the structure clearance for lead movement (e.g., ribs, various thicknesses, collapsing sections/points, coatings, films, jackets, and the like).
  • Once the tissue growth is dilated by, inter alia, a lead removal sleeve, subsequent movement of the lead relative to the section of tissue growth can be achieved using various lead removal techniques, including but not limited to, the use of traction applied to the lead, lead locking devices, snares, additional sheath and/or structure insertion, moving the lead within a lead removal sleeve, and the like.
  • Accordingly, there is a need for a device, method and/or system such as a device that includes a sleeve having an outer surface, a distal end, a proximal end, and an inner lumen running from the proximal to the distal end, wherein the sleeve facilitates the dilation of formed tissue surrounding a lead, and optionally a method and system capable of removing the lead from the formed tissue and/or sleeve that captures at least a portion of an implanted lead.
  • In an embodiment, a lead removal apparatus is provided comprising: a shaft, wherein the shaft is flexible, the shaft having at least one outer surface, a proximal and a distal end, and wherein the shaft includes an inner lumen running from the proximal to the distal end to receive at least one of an implanted object and a mechanical traction device; and a tissue dilating tip disposed adjacent to the distal end of the shaft, wherein the tissue dilating tip is configured to passively wedge into an area between a tissue growth and the implanted object, and wherein the at least one outer surface of the lead removal apparatus is configured to dilate the tissue growth about an area of the implanted object.
  • In another embodiment, a lead removal method is provided, the method comprising: engaging a lead removal apparatus over an implanted object in a patient; passively dilating a length of tissue growth surrounding the implanted object; and thereafter removing the implanted object from the tissue growth. In one embodiment, the passively dilating and thereafter removing steps may comprise the sub-steps: attaching a mechanical traction device to the implanted object; inserting the mechanical traction device into the lead removal apparatus, the lead removal apparatus further comprising: a flexible shaft, wherein the flexible shaft has a proximal and a distal end; an internal lumen, wherein the internal lumen is configured to allow at least one of an implanted object and mechanical traction device to pass therethrough; and a tissue dilating tip operatively connected to the distal end of the flexible shaft; applying a mechanical traction force to the mechanical fraction device; indexing the lead removal apparatus to an engagement area of the tissue growth in contact with the implanted object; and moving the tissue dilating tip into the tissue growth, such that the tissue growth is dilated around the flexible shaft and dislocated from the implanted object at least at the engagement area with the tissue dilating tip.
  • In yet another embodiment, a system to remove a lead from a vascular lumen is provided, the system comprising: a lead locking device for locking onto a lead within the vascular lumen; a flexible shaft comprising: a proximal end; a distal end comprising a tip capable of passively dilating and directing tissue about a lead; and an internal lumen configured to allow at least one lead to pass therethrough, wherein the lead locking device holds the lead while the tip dilates tissue surrounding at least a portion of the lead.
  • The method can include the steps of inserting a lead removal sleeve in an area between an implanted object and at least a portion of a tissue growth at least substantially surrounding the implanted object in a patient and thereafter removing the implanted object. The lead removal sleeve can be inserted along an entire length of a tissue growth in an area between an implanted object and the tissue growth. In some cases, the lead removal sleeve may be inserted along only a partial length, not an entire length, of a tissue growth in an area between the implanted object and the tissue growth.
  • The lead removal sleeve may be manufactured as an extruded shape of substantially uniform cross-sectional area. Additionally or alternatively, the distal and or proximal end of the lead removal sleeve may be shaped to include a surface and/or geometry other than the substantially uniform cross-sectional area. For example, the lead removal sleeve may include a tissue dislocation, or dilation, tip disposed at or adjacent to the distal end of the sleeve. In some cases, the tissue dislocation tip may be configured to contact and direct at least a portion of tissue growth away from contacting a surface of an implanted lead. For instance, the tissue dislocation tip may be configured to wedge into an area between the tissue growth and an implanted lead. In one case, as the wedge is inserted into an area between the tissue growth and the implanted lead, the tissue may be caused to dilate about an outer surface of the lead removal sleeve. In other words, the tissue dislocation tip may be configured to “passively” wedge into the area between the tissue growth and the implanted lead, that is, without substantially cutting or disrupting the formation of the tissue growth. As can be appreciated, the tissue dislocation tip may include one or more of various shapes, thicknesses, hardnesses, materials, and the like.
  • Removal of the implanted lead from the formed tissue, or tissue growth, may be effected by creating clearance between the lead and the tissue growth. By dilating the formed tissue along an axial portion, or length, of the tissue in contact with the surgically implanted device or surgical implant, it is anticipated that the tissue may stretch around at least a portion of the outer surface of the lead removal sleeve. The outer surface of the lead removal sleeve acts to support the tissue growth in a dilated state. As such, the lead may move within the inner lumen of the lead removal sleeve without being subjected to any constriction forces subjected by the tissue growth. These and other needs are addressed by the various aspects, embodiments, and/or configurations of the present disclosure. Also, while the disclosure is presented in terms of exemplary embodiments, it should be appreciated that individual aspects of the disclosure can be separately claimed.
  • The lead removal sleeve includes a flexible shaft having a proximal end, a distal end, and an internal lumen having an internal diameter configured to allow a lead, lead locking device, and/or other implanted device to pass through it. The sleeve may also include a tissue dislocation tip operatively coupled with the distal end of the flexible shaft. As can be appreciated, the dislocation and/or dilation of formed tissue can be performed by at least one of moving, directing, displacing, dilating, expanding, wedging, and combinations thereof. It is anticipated that the lead removal sleeve may be oriented within a patient via use of the flexible shaft and monitor, or a catheter-based system. In some cases, the lead removal sleeve may be positioned over an implanted lead, such that the tissue dislocation tip is caused to contact tissue growth in contact with the lead.
  • Among other things, the lead removal sleeve may be constructed such that the sleeve may wedge into an area between the tissue growth surrounding an implanted lead via a force transmitted along the flexible shaft. Additionally or alternatively, the flexible portion may be configured to allow the lead removal sleeve to move as directed within a patient.
  • The phrases “at least one”, “one or more”, and “and/or” are open-ended expressions that are both conjunctive and disjunctive in operation. For example, each of the expressions “at least one of A, B and C”, “at least one of A, B, or C”, “one or more of A, B, and C”, “one or more of A, B, or C” and “A, B, and/or C” means A alone, B alone, C alone, A and B together, A and C together, B and C together, or A, B and C together. When each one of A, B, and C in the above expressions refers to an element, such as X, Y, and Z, or class of elements, such as X1-Xn, Y1-Ym, and Z1-Zo, the phrase is intended to refer to a single element selected from X, Y, and Z, a combination of elements selected from the same class (e.g., X1 and X2) as well as a combination of elements selected from two or more classes (e.g., Y1 and Zo).
  • The term “a” or “an” entity refers to one or more of that entity. As such, the terms “a” (or “an”), “one or more” and “at least one” can be used interchangeably herein. It is also to be noted that the terms “comprising”, “including”, and “having” can be used interchangeably.
  • The term “bioresorbable” may be used herein to refer to the property of a material manufactured to degrade, biodegrade, bioabsorb, dissolve, and/or be absorbed by a body. Bioresorbable materials may include, but are in no way limited to, iron, magnesium, metals, alloys thereof, polymers, amino-acid based polymers, polyester amides, silica composites, coatings, and combinations thereof. Bioresorbable materials may be controlled to degrade over a period of time by incorporating layers of materials and/or coatings in specific combinations. Such combinations may include constructing various material layers, including coatings, with known degradation rates in an order that may facilitate degradation over a designed time period.
  • A “lead” is a conductive structure, typically an electrically insulated coiled wire. The electrically conductive material can be any conductive material, with metals and intermetallic alloys common. The outer sheath of insulative material is biocompatible and biostable (e.g., non-dissolving in the body) and generally includes organic materials such as ultra high weight polyethylene, polyurethane, and polyimide. Lead types include, by way of non-limiting example, epicardial and endocardial leads. Leads are commonly implanted into a body percutaneously or surgically.
  • A “surgical implant” is a medical device manufactured to replace a missing biological structure, support, stimulate, or treat a damaged biological structure, or enhance, stimulate, or treat an existing biological structure. Medical implants are man-made devices, in contrast to a transplant, which is a transplanted biomedical tissue. In some cases implants contain electronics, including, without limitation, artificial pacemaker, defibrillator, electrodes, and cochlear implants. Some implants are bioactive, including, without limitation, subcutaneous drug delivery devices in the form of implantable pills or drug-eluting stents.
  • The term “means” as used herein shall be given its broadest possible interpretation in accordance with 35 U.S.C., Section 112, Paragraph 6. Accordingly, a claim incorporating the term “means” shall cover all structures, materials, or acts set forth herein, and all of the equivalents thereof. Further, the structures, materials or acts and the equivalents thereof shall include all those described in the summary of the invention, brief description of the drawings, detailed description, abstract, and claims themselves.
  • It should be understood that every maximum numerical limitation given throughout this disclosure is deemed to include each and every lower numerical limitation as an alternative, as if such lower numerical limitations were expressly written herein. Every minimum numerical limitation given throughout this disclosure is deemed to include each and every higher numerical limitation as an alternative, as if such higher numerical limitations were expressly written herein. Every numerical range given throughout this disclosure is deemed to include each and every narrower numerical range that falls within such broader numerical range, as if such narrower numerical ranges were all expressly written herein.
  • The preceding is a simplified summary of the disclosure to provide an understanding of some aspects of the disclosure. This summary is neither an extensive nor exhaustive overview of the disclosure and its various aspects, embodiments, and configurations. It is intended neither to identify key or critical elements of the disclosure nor to delineate the scope of the disclosure but to present selected concepts of the disclosure in a simplified form as an introduction to the more detailed description presented below. As will be appreciated, other aspects, embodiments, and configurations of the disclosure are possible utilizing, alone or in combination, one or more of the features set forth above or described in detail below
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The accompanying drawings are incorporated into and form a part of the specification to illustrate several examples of the present disclosure. These drawings, together with the description, explain the principles of the disclosure. The drawings simply illustrate preferred and alternative examples of how the disclosure can be made and used and are not to be construed as limiting the disclosure to only the illustrated and described examples. Further features and advantages will become apparent from the following, more detailed, description of the various aspects, embodiments, and configurations of the disclosure, as illustrated by the drawings referenced below.
  • FIG. 1 shows an exemplary patient vasculature in section with implanted lead and multiple locations of tissue growth in accordance with some embodiments of the present disclosure;
  • FIG. 2A shows a detail section view of a patient vasculature and implanted lead subjected to a traction force in a first path in accordance with some embodiments of the present disclosure;
  • FIG. 2B shows a detail section view of a patient vasculature and implanted lead subjected to a traction force in second path in accordance with some embodiments of the present disclosure;
  • FIG. 2C shows a detail section view of a patient vasculature and implanted lead subjected to a traction force in third path in accordance with some embodiments of the present disclosure;
  • FIG. 3 shows a section view of a curved area of vasculature with tissue growth formed around an implanted lead in accordance with embodiments of the present disclosure;
  • FIG. 4 shows a cross-sectional view of the curved area of vasculature of FIG. 3 taken along line A-A;
  • FIG. 5A shows a cross-sectional view of an area of vasculature with a lead removal sleeve introduced along an implanted lead in accordance with embodiments of the present disclosure;
  • FIG. 5B shows a cross-sectional view of an area of vasculature with a lead removal sleeve engaging and dilating formed tissue surrounding an implanted lead in accordance with embodiments of the present disclosure;
  • FIG. 5C shows a cross-sectional view of an area of vasculature with a lead removal sleeve dilating formed tissue along an entire length of the formed tissue surrounding an implanted lead in accordance with embodiments of the present disclosure;
  • FIG. 5D shows a cross-sectional view of an area of vasculature with an implanted lead subjected to a removal force within an area of a lead removal sleeve dilating formed tissue along an entire length of the formed tissue in accordance with embodiments of the present disclosure;
  • FIG. 5E shows a cross-sectional view of an area of vasculature with a lead removal sleeve in a tissue growth after a lead has been removed from the area in accordance with embodiments of the present disclosure;
  • FIG. 5F shows a cross-sectional view of an area of vasculature with a lead removal sleeve within an area of a tissue growth where the sleeve is subjected to removal forces in accordance with embodiments of the present disclosure; and
  • FIG. 6 is a flow diagram depicting a lead removal method in accordance with embodiments of the present disclosure.
  • It should be understood that the drawings are not necessarily to scale. In certain instances, details that are not necessary for an understanding of the disclosure or that render other details difficult to perceive may have been omitted. It should be understood, of course, that the disclosure is not necessarily limited to the particular embodiments illustrated herein.
  • DETAILED DESCRIPTION
  • Before any embodiments of the disclosure are explained in detail, it is to be understood that the disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The disclosure is capable of other embodiments and of being practiced or of being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items.
  • Embodiments of the present disclosure are directed to lead removal sleeves and methods of using lead removal sleeves to remove an implanted lead from within the vascular system of a patient. Among other things, the method of removing an implanted lead from formed tissue may include causing at least a partial dilation of tissue along an axial length of the implanted lead. In some embodiments, the tissue may be “passively” dilated and displaced (e.g., without cutting or otherwise disrupting the continuity of the tissue growth) by a lead removal sleeve along an entire length of the tissue growth to enable removal of the implanted lead. In other embodiments, the tissue may be dilated and displaced about a lead removal sleeve, where the lead removal sleeve provides support to maintain the tissue in a dilated state. Additionally or alternatively, the lead removal sleeve may provide clearance between the inner lumen of the sleeve and the lead to allow an implanted lead to be removed from a patient.
  • While the phrases “tissue displacing tip” or “tissue dilating tip” are used in this disclosure, it is not limited to an extruded shape of uniform cross-section. These phrases are further intended to encompass any modality for dilating or displacing tissue, including the various modalities discussed herein. Nonlimiting examples include not only a tapered area, point, or shaped end disposed at or near the distal end of the sleeve, but also a machined tip, formed tip, welded and/or tip otherwise connected to the flexible shaft of the lead removal sleeve.
  • FIG. 1 depicts an exemplary patient 102 with an implanted lead 104 running along the left innonimate vein 112 past the superior vena cava (“SVC”) 116 and connected into, or about, the right ventricle of the heart 106. Along the length of the lead 104 at least one formed tissue growth 108 is shown where the tissue 108 may completely surround a section of the lead 104. In a typical lead 104 explant procedure, the one or more of the tissue growths 108 may act to contain the lead 104. For example, the tissue 108 may impart one or more forces (e.g., constrictive, shear, compression, and the like) on the lead 104 that may act to prevent successful removal of the lead 104 when subjected to a traction force 120.
  • FIGS. 2A-C show examples of an implanted lead 104 subjected to a traction force via different paths in a patient 102 vasculature. Accordingly, the methods and/or devices disclosed in conjunction with any of the FIGS. 2A-C may equally apply to all instances disclosed.
  • FIG. 2A shows a detail view of a heart 106 having an implanted lead 104 subjected to a traction force 120 in a first path in accordance with embodiments of the present disclosure. In some embodiments, a lead 104 explant procedure may involve removing the lead from a patient 102 via one or more paths. For example, a lead-locking, or other traction, device may be engaged with the lead 104 and then used to pull the lead 104 from a patient. However, in some cases the lead 104 may be contained by a formed tissue growth 108 that resists the traction force 120 applied to the lead 104. As can be appreciated, subjecting the lead 104 to excessive traction forces 120 may cause a tear inside the patient 102 where the tissue is attached to the vasculature. In one example, a tissue growth 108 may form along a critical area of the vasculature, such as the SVC curve 116, of a patient. If this critical area is torn during a lead 104 explant procedure, the result can be fatal to the patient 102.
  • Complicating the lead 104 removal process is the fact that the tissue growth 108 surrounding a lead 104 may attach to a vessel in a curved portion of the vasculature. Removal of the lead 104 from such a curved portion of vasculature can present a challenge when introducing tissue removal devices alone or in conjunction with traction devices. In some cases, the tissue removal devices include sharp edges, aggressive tips, or imprecise actuation mechanisms that can puncture the thin walls of a patient 102 vasculature. It is an aspect of the present disclosure to orient any sharp edge of a tissue dislocation tip associated with a lead removal sleeve adjacent to the unconnected, or tissue free, side 124 of a vessel wall. This orientation can prevent puncture and/or damage occurring to the vasculature at the tissue connected side 128 of the vessel wall.
  • Referring now to FIG. 2B a detail section view of a patient vasculature and implanted lead 104 subjected to a traction force 120 in second path in accordance with some embodiments of the present disclosure is shown. In some instances, at least one end of the lead 104 may be directed inside a patient 102 for removal via a path within the vasculature. Direction of the lead 104 may be effected via a snaring tool, lead-locking device, traction device, combinations thereof, and the like. As shown in FIG. 2B, the lead 104 is directed toward the general direction of a patient's femoral artery via the inferior vena cava. The lead 104 may be directed in the manner shown to provide additional tearing forces on the tissue growth 108 by the lead 104 being subjected to a traction force 120. In one embodiment, a lead removal sleeve may be run along the lead 104 to the tissue growth 108 via the femoral artery.
  • In some embodiments, the lead 104 may be captured and pulled such that the pull force causes the lead 104 to turn inside a patient 102. This mode of capture and pulling may cause a bending at a first connection point between the tissue growth 108 and the lead 104. When the lead removal sleeve is engaged with the tissue growth 108, the assistive bending force provided by the traction force 120 can aid in dilating the tissue growth 108. For instance, the bending force may cause a stretching of the tissue growth 108 where the lead engages with the tissue growth 108. This stretching of tissue may assist in the dilating operation by causing tension on the fibers of the tissue growth 108 that provide a greater area for introduction of a lead removal sleeve. As can be expected, the dilating operation may be performed in any area within a patient that is capable of receiving a lead removal sleeve.
  • FIG. 2C shows a detail section view of a patient vasculature and implanted lead 104 subjected to a traction force 120 in third path in accordance with some embodiments of the present disclosure. Similar to FIGS. 2A and 2B, the lead 104 may be directed along a path in the patient vasculature. In this case, the lead 104 may be directed toward the general direction of a patient's jugular vein.
  • As can be appreciated, the path chosen for removal of a lead 104 from a patient 102 may depend on one or more of the orientation of the lead 104 within a patient 102, the state of the at least one tissue growth 108 and the lead removal device used. In some cases, the lead 104 (e.g., pacing, defibrillator, etc.), or other object, may have moved after implantation. In these scenarios, the lead 104 may have to be captured via some other method. In some embodiments, a capturing tool equipped with a lasso, snare, or other lead grasping element may need to be inserted into the patient 102. As can be expected, the capturing tool may be inserted into the patient 102 via any number of the veins and/or arteries that are interconnected to the lead 104 location in the vasculature. For example, the lead 104 may be grasped via a capturing tool that has been inserted through a patient's femoral artery and led to the point of the vasculature where the lead's 104 free end may be located.
  • In some embodiments, rather than attach a separate mechanical traction device, the capturing tool may be used to provide traction force 120 during the tissue dilation operation. In accordance with embodiments of the present disclosure, the lead may be grasped via a capturing tool, or lead-locking device, and/or removed via some other pathway in the vasculature. In other words, the lead may be accessed via one or more veins, arteries, chambers, biological channels, and/or other sections of the vasculature of a patient 102.
  • FIG. 3 shows a section view of a curved area of vasculature with tissue growth 108 formed around an implanted lead 104 in accordance with embodiments of the present disclosure. The tissue growth 108 may completely surround a section of the lead 104 and even be attached to a vessel wall at a tissue connected side 128 of the vasculature. In some cases, the tissue growth 108 may not be adhered to at least one free side 124 of a vessel, such that a vessel opening 126 exists where bodily fluid may pass through the vessel unobstructed. Surprisingly and unexpectedly, it has been discovered that the tissue growth 108, before attempted lead extraction, is commonly at least substantially free of and even more commonly completely free of attachment to the lead 104.
  • FIG. 4 shows a cross-sectional view of the curved area of vasculature of FIG. 3 taken along line A-A. In some embodiments, reference may be made to the tissue growth 108 forming a tube 132 (or cylindrical or sock-like structure) around the implanted lead 104. Previous methods have been disclosed that are directed to separating the tissue around the lead 104 in the area defined by the tube 132.
  • FIGS. 5A-F show a cross-section of a vessel where a lead removal sleeve 504 is progressively engaged with a tissue growth 108 for lead 104 removal. As shown, the lead removal sleeve 504 causes a section of the tissue growth 108 to dilate around at least a portion of the lead 104 allowing the forces containing the lead 104 to be directed to a structure 506 of the lead removal sleeve 504. An implanted lead 104 may be removed from the vasculature through the lead removal sleeve 504. Additionally or alternatively, the lead removal sleeve 504 may be removed from the vasculature.
  • Referring to FIG. 5A a cross-sectional view of an area of vasculature with a lead removal sleeve 504 introduced therein in accordance with embodiments of the present disclosure is shown. The lead removal sleeve 504 includes a flexible shaft having a proximal and a distal end, an inner lumen 510 running from the proximal to the distal end, and a tissue dislocation tip 508 disposed at or near the distal end of the shaft that is configured to dilate at least a portion of tissue growth 108 formed around an area of an implanted lead 104. As can be appreciated, the tissue dislocation tip 508 may be the distal end of the shaft and/or operatively attached adjacent to the distal end of the shaft. In some embodiments, the inner lumen 510 may include an internal diameter configured to allow a lead, lead locking device, and/or other implanted device to pass through it.
  • In another embodiment, a lead removal sleeve 504 may be configured to work into an area between a tissue growth 108 and a lead 104. It is anticipated that the geometry of the lead removal sleeve 504 and/or the tissue dislocation tip 508 may allow the lead removal sleeve 504 to be worked into this area. For instance, the lead removal sleeve 504 may be constructed with a thin wall between the inner lumen 510 and an outer surface of the structure 506 of the lead removal sleeve 504. An example of this thin wall may include a thickness range from 0.005″ to 0.1875.″ In some embodiments, the thickness may vary at the tissue dislocation tip 508, such that a thickness at the tip 508 is less than a thickness along another portion of the lead removal sleeve 504 proximal to the tissue dislocation tip 508. This variation in thickness may act to wedge the tissue dislocation tip 508 into the area between the tissue growth 108 and the lead 104. Depending on the tissue growth 108, various thicknesses may be required to work into an area between the tissue growth 108 and the lead 104. Tougher tissue growths 108 may require a thinner wall thickness of the lead removal sleeve 504, while softer tissue growths 108 may allow for a greater wall thickness of the lead removal sleeve 504. The lead removal sleeve 504, and/or its constituent parts, may be manufactured from any plastic, metal, resin, composite material, and/or combinations thereof disclosed herein. For example, the lead removal sleeve 504 may be manufactured from the same material as the inner lumen 510 and vice versa. In some embodiments, the lead removal sleeve 504 may be manufactured as a single extruded piece, as a tri-coil assembly, and even as a combination of various components.
  • In one embodiment, the tissue dislocation tip 508 may be oriented such that a leading edge may be presented to a section of tissue growth 108 between the lead 104 and the open area 126 of a vessel. Orientation of the lead removal sleeve 504 may be achieved in operation via a fluoroscopy and/or other monitoring devices and the use of one or more radiopaque markers on the lead removal sleeve 504. Additionally or alternatively, an orientation of the lead removal sleeve 504 may be achieved via a monitoring device operatively attached to the lead removal sleeve 504. In some embodiments, the monitoring device may be operatively attached to the distal end of the lead removal sleeve 504. Once the lead removal sleeve 504 is oriented, the lead removal sleeve 504 may contact the tissue growth 108 at an engagement area 516.
  • FIG. 5B shows a cross-sectional view of an area of vasculature with a lead removal sleeve 504 engaging formed tissue 108 in accordance with embodiments of the present disclosure. The lead removal sleeve 504 may be pushed, indexed, and/or gradually rotated into the formed tissue 108. The directional force 518 may be applied to the lead removal sleeve 504 via one or more mechanical actuators, electrical actuators, manual positioning, and combinations thereof. As the lead removal sleeve 504 engages the tissue growth 108 the tissue dislocation tip 506, may dilate the tissue growth 108 by dislocating, expanding, stretching, parting, and/or otherwise causing a separation of tissue 520 at the engagement area 516. In some embodiments, as the lead removal sleeve 504 is engaged with the tissue growth 108, the separation of tissue 520 redirects forces (e.g., clamping, constricting, compression, etc.) subjected to the lead 104 by the tissue growth 108 to be directed to an outer surface associated with the flexible shaft 506.
  • FIG. 5C shows a cross-sectional view of an area of vasculature with a lead removal sleeve 504 dilating a complete length of a tissue growth 108 in accordance with embodiments of the present disclosure. As shown in FIG. 5C, the tissue growth 108 is dilated by the lead removal sleeve 504 along a section of the lead 104. In some embodiments, a structure 506 of a lead removal sleeve 504 may provide support to maintain the tissue growth 108 in a dilated state. Additionally or alternatively, the inner lumen 510 of the lead removal sleeve 504 may provide clearance for the lead 104 to move relative to the tissue growth 108 and the lead removal sleeve 504.
  • FIG. 5D shows a cross-sectional view of an area of vasculature with an implanted lead 104 subjected to a removal force 522. As can be appreciated, the lead 104 may create a tunnel, through which, the lead 104 may be moved (e.g., removed from a patient and/or tissue growth 108). The tunnel provided by the lead removal sleeve 504 may prevent forces from the tissue growth 108 from acting on the lead 104. In some embodiments, the inner lumen 510 of the lead removal sleeve 504 may be configured with a low-friction surface for an implanted lead 104, lead-locking device, and/or other object to move along. It is anticipated that the low-friction surface may prevent the lead from adhering to the inner lumen 510. Examples of low-friction surfaces of the inner lumen 510 may include, but are not limited to, a manufactured shape (e.g., smooth, uninterrupted, sinusoidal, undulated, etc.), a material with a low coefficient of friction (e.g., polytetrafluroethylene (“PTFE”), fluropolymer, polymers, plastics, resins, metal alloy, steel alloy, etc.), a lining, a deposited film, rollers, liquid bearing, polished material, and the like. In one embodiment, the low-friction surface may include a surface with a coefficient of friction (“μ”) less than 1. In other words, a force required to slide an object along a low-friction surface having a μ<1, is less than the normal force of the object acting against the low-friction surface.
  • FIG. 5E shows a cross-sectional view of an area of vasculature with a lead removal sleeve 504 in a tissue growth 108 after a lead 104 has been removed in accordance with embodiments of the present disclosure. In some embodiments, the lead removal sleeve 504 may continue to dilate the tissue growth 108 even after a lead 104 has been removed. The lead removal sleeve 504 may be configured and/or allowed to remain inside the vasculature of a patient 102. In one instance, the lead removal sleeve 504 may be manufactured from or include at least one bioresorbable material. As such, the lead removal sleeve 504 may be left inside of a patient 102 to degrade and/or be absorbed by the patient 102 over time. In an alternative embodiment, the lead removal sleeve 504 may be manufactured from a non-bioresorbable material, where the sleeve 504 is left inside a patient without appreciably degrading over time. It is anticipated that the non-bioresorbable material of the lead removal sleeve may be manufactured from a biocompatible material configured to remain inside a patient 102 indefinitely. Alternatively, the lead removal sleeve 504 may be subsequently removed from the vasculature of the patient 102.
  • FIG. 5F shows a cross-sectional view of an area of vasculature with a lead removal sleeve 504 within an area of a tissue growth 108 where the sleeve 504 is subjected to removal forces in accordance with embodiments of the present disclosure. The lead removal sleeve 504 may be pulled from a tissue growth 108 in a removal direction 526. In some embodiments, as the lead removal sleeve 504 is pulled (e.g., via a removal force) from a tissue growth 108, one or more forces subjected to an outer diameter of the sleeve 504 may cause the sleeve 504 to radially collapse. In another embodiment, the lead removal sleeve 504 may be subjected to a twisting removal force to collapse the sleeve 504. It is anticipated that the twisting removal force may be in a rotational direction about an axis running along the lead removal sleeve. For example, the twisting force may cause the lead removal sleeve 504 to reduce an inner and outer overall diameter of the sleeve 504 such that forces subjected to the lead via a tissue growth 108 are reduced and/or eliminated. Additionally or alternatively, the lead removal sleeve 504 may include one or more stress concentration areas, and/or collapsible sections, that may be configured to collapse along a given section, area, point, and/or line. As can be appreciated, the one or more stress concentration areas and/or collapsible sections may collapse when subjected to a specific force or combination of forces.
  • In one embodiment, the lead removal sleeve 504 may be collapsed along its length in a direction 524 toward an axis running along the length of the sleeve 504. Additionally or alternatively, the lead removal sleeve 504 may be configured to collapse along a section of the sleeve structure 506. In an embodiment, it is anticipated that the lead removal sleeve 504 may include at least one weakened, or reduced thickness, area along a length of the structure 506.
  • In any of the collapsing embodiments disclosed herein, it is anticipated that the collapsing of a section of the lead removal sleeve 504 will allow a dilated section 520 of the tissue growth 108 to remain dilated about the lead removal sleeve 504. As such, any forces subjected to the structure 506 of the uncollapsed sleeve 504 will be at least temporarily reduced on the collapsed sleeve. This temporary reduction in forces may allow the lead removal sleeve 504 to be removed from the tissue growth 108 by subjecting the sleeve 504 to a removal force.
  • Referring to FIG. 6, a lead removal method 600 will be described in accordance with at least some embodiments of the present disclosure. The method 600 starts at 604 and begins by connecting a lead-locking device or other traction device to the lead 104 (step 608). In some embodiments, the lead-locking device may be inserted into the core of an implanted lead 104. In other embodiments, a traction device may be connected to the lead 104 to provide traction on the lead 104. For instance, mechanical traction can be achieved in leads 104 by inserting a locking stylet into the lead 104 and applying a pull force onto the lead 104 via the locking stylet. In some embodiments, it may be beneficial to support the lead removal sleeve 504 and/or lead locking device with another structure. For instance, the lead removal sleeve 504 may be inserted into a support catheter. The support catheter may be inserted adjacent to the tissue growth 108 and may be configured to at least partially contain and/or restrain movement associated with the lead removal sleeve 504. In one embodiment, the support catheter may include a vacuum system that may be configured to direct a vacuum force to an outer diameter of the lead removal sleeve 504. The vacuum system may be selectively operated to allow free movement and/or restrict movement based on an unapplied vacuum and an applied vacuum, respectively. In some embodiments, the vacuum may be contained adjacent to an inner diameter of the support catheter.
  • Once a traction device is attached to the lead 104, the traction device can be threaded through the internal, or inner, lumen 510 of a lead removal sleeve 504 (step 612). For example, the lead-locking device may be inserted through the lumen in an implanted lead 104 and attached to the internal portions of the implanted lead 104, which can be at the distal portion or proximal to the distal portion of the lead 104. The lead removal sleeve 504 may ride over an external portion of the lead 104 and lead-locking device and may be configured to dilate tissue growths 108 along an axial length of the tissue 108 in contact with the lead 104.
  • As the lead removal sleeve 504 is engaged with the lead 104, a slight traction force may be applied to the lead 104 to allow the lead removal sleeve 504 to guide along the lead 104 (step 616). The lead removal sleeve 504 can be moved toward a first formed tissue growth 108 while applying a mechanical traction force to the lead 104 itself or through a locking stylet, or other traction device. Mechanical traction force should be applied with appropriate force to prevent tearing a vein or artery wall by moving the lead 104 and tissue 108 before they are dislocated. In some embodiments, the lead removal sleeve may be observed moving inside a patient 102 via a fluoroscope or other monitor. It is anticipated that the tissue dislocation tip 508, or some other area, of the lead removal sleeve may include a fluorescing material or marker (e.g., radiopaque band, and the like). This fluorescing material or marker may be used to aid in monitoring the movement of the lead removal sleeve when it is inside a patient 102. Additionally or alternatively, the lead removal sleeve 504 may include a monitoring system disposed at or adjacent to the distal end of the sleeve 504 to determine a location of the sleeve and/or the tissue dislocation tip inside a patient 102.
  • Next, the sleeve 504 is moved into contact with the formed tissue growth 108 (step 620). In some embodiments, a sharp, tapered, or leading edge of the tissue dislocation tip 508 of the lead removal sleeve 504 may be oriented toward the center of the vein, or away from the vein wall connecting the lead 104 to the vein. In addition to preventing accidental puncture, trauma, or other damage to the delicate surfaces of the vasculature this orientation of the tissue dislocation tip 508 may aid in safely actuating the sleeve 504 and dilating the tissue 108 about the implanted lead 104. For example, a lead removal sleeve 504 may include a tissue dislocation tip 508 with a wedge and/or tapered portion adjacent to the distal end of the sleeve 504. It is anticipated that this tissue dislocation tip 508 may be configured to wedge into an area between the tissue growth 108 and a lead. As the lead removal sleeve 504 traverses along the lead 104, the tissue dislocation tip 508 continues to dilate the tissue growth 108. Additionally the leading portion, which may include a wedge and/or tapered portion, can act to cause a stretching of the formed tissue growth 108 at the point where it engages with the tissue dislocation tip 508. This stretching of tissue may assist in the actuating the lead removal sleeve further into the tissue growth 108. In addition, the stretching of tissue may aid in redirecting forces created by the tissue growth 108 from contacting the lead 104 to contacting the structure of the sleeve 504.
  • Once the tissue dislocation tip is engaged with, and/or dilating, the formed tissue 108, the lead removal sleeve 504 may be actuated and moved along the lead 104 to further engage with the tissue growth 108. In some embodiments, the lead removal sleeve 504 may be indexed forward (into the tissue formation 108) continuously or periodically. In other embodiments, the lead removal sleeve 504 may be repeatedly indexed into and removed from the engagement area of the formed tissue growth 108. It is anticipated that each time the lead removal sleeve 504 is indexed into the engagement area the sleeve 504 can dilate a successively longer section of the formed tissue 108. Indexing the sleeve 504 along the lead 104 and into a tissue growth 108 may require a rotational movement of the sleeve 504 about an axis running from the proximal to the distal end of the sleeve 504. In some cases, the lead removal sleeve 504 may be worked into an area between the tissue growth 108 and the lead 104 by rotating and translating the sleeve 504.
  • The method 600 may be continued by determining whether a traction force applied to the lead 104 moves the lead 104 relative to the tissue growth 108 and/or the lead removal sleeve 504 (step 624). In the event that the lead 104 is determined to move such that it may be removed from the patient, the method may continue at step 632. If it is determined, however, that the lead 104 does not move sufficiently relative to the tissue growth 108 and/or the lead removal sleeve 504, the method may continue at step 628.
  • In some cases, the lead removal sleeve 504 may need to be worked through an entire length of a tissue growth 108 and/or worked through more than one tissue growth 108 such that the lead 104 may be removed from a patient 102 (step 628). Accordingly, the lead removal sleeve 504 may be indexed through one or more tissue growths 108 until it is determined (at step 624) that the lead 104 can be moved/removed.
  • Once the lead is determined to move relative to the tissue growth 108 and/or lead removal sleeve 504, the method may continue at step 632 by removing the lead 104 from the patient 102 (step 632). Additionally or alternatively, once the tissue growth(s) have been dilated, the lead 104 may be removed by applying a pull force to the lead-locking device in the same direction as the mechanical traction force previously applied to the lead 104. It is anticipated that any movement of the lead removal sleeve 504 may be accompanied by an applied mechanical traction force to the lead 104/lead-locking device.
  • In some embodiments, the method 600 may continue by removing the lead removal sleeve 504 from the patient 102 (step 636). Otherwise, the method 600 ends at step 640. As disclosed herein, a lead removal sleeve 504 may be removed from a patient 102 via collapsing an area of the structure 506 of the lead removal sleeve 504. In one embodiment, the lead removal sleeve 504 may be twisted about an axis running along the sleeve 504. As the sleeve 504 is twisted, an inner and/or outer diameter associated with the sleeve 504 may be caused to reduced in diameter. This reduction in diameter may reduce forces subjected to the sleeve 504 via the tissue growth 108. In one embodiment, it is anticipated that the tissue growth 108 surrounding a twisted sleeve 504 may remain in a temporarily dilated state after the sleeve 504 is collapsed. This temporarily dilated state of the tissue growth 108 may allow for removal of the lead removal sleeve 504 by subjecting the lead removal sleeve 504 to a directional removal force configured to dislocate a position of the sleeve 504 (e.g., pulling the sleeve 504 from the patient 102).
  • Embodiments of the present disclosure anticipate using a mechanical collapse structure to remove the sleeve 504 from a patient 102. For instance, the lead removal sleeve 504 may incorporate one or more mechanical elements, such as, cams, wires, coils, removable strips, combinations thereof, and the like to facilitate a mechanical collapse of the structure 506 of the sleeve 504. Once the sleeve structure 506 is collapsed it may be removed from a patient 102 in a similar manner as disclosed above. The method 600 ends at step 640.
  • In the appended figures, similar components and/or features may have the same reference label. Further, various components of the same type may be distinguished by following the reference label by a letter that distinguishes among the similar components. If only the first reference label is used in the specification, the description is applicable to any one of the similar components having the same first reference label irrespective of the second reference label.
  • Presented herein are embodiments of a lead removal sleeve, system, and method. As described herein, the device(s) may be electrical, mechanical, electro-mechanical, and/or combinations thereof.
  • Also, while the flowcharts have been discussed and illustrated in relation to a particular sequence of events, it should be appreciated that changes, additions, and omissions to this sequence can occur without materially affecting the operation of the disclosed embodiments, configuration, and aspects.
  • A number of variations and modifications of the disclosure can be used. It would be possible to provide for some features of the disclosure without providing others. By way of illustration, any methodology or modality of dislocating and/or dilating tissue may be employed as described herein to effect lead removal from an encased tissue growth.
  • The present disclosure, in various aspects, embodiments, and/or configurations, includes components, methods, processes, systems and/or apparatus substantially as depicted and described herein, including various aspects, embodiments, configurations embodiments, subcombinations, and/or subsets thereof. Those of skill in the art will understand how to make and use the disclosed aspects, embodiments, and/or configurations after understanding the present disclosure. The present disclosure, in various aspects, embodiments, and/or configurations, includes providing devices and processes in the absence of items not depicted and/or described herein or in various aspects, embodiments, and/or configurations hereof, including in the absence of such items as may have been used in previous devices or processes, e.g., for improving performance, achieving ease and/or reducing cost of implementation.
  • The foregoing discussion has been presented for purposes of illustration and description. The foregoing is not intended to limit the disclosure to the form or forms disclosed herein. In the foregoing Summary for example, various features of the disclosure are grouped together in one or more aspects, embodiments, and/or configurations for the purpose of streamlining the disclosure. The features of the aspects, embodiments, and/or configurations of the disclosure may be combined in alternate aspects, embodiments, and/or configurations other than those discussed above. This method of disclosure is not to be interpreted as reflecting an intention that the claims require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive aspects lie in less than all features of a single foregoing disclosed aspect, embodiment, and/or configuration. Thus, the following claims are hereby incorporated into this Summary, with each claim standing on its own as a separate preferred embodiment of the disclosure.
  • Moreover, though the description has included description of one or more aspects, embodiments, and/or configurations and certain variations and modifications, other variations, combinations, and modifications are within the scope of the disclosure, e.g., as may be within the skill and knowledge of those in the art, after understanding the present disclosure. It is intended to obtain rights which include alternative aspects, embodiments, and/or configurations to the extent permitted, including alternate, interchangeable and/or equivalent structures, functions, ranges or steps to those claimed, whether or not such alternate, interchangeable and/or equivalent structures, functions, ranges or steps are disclosed herein, and without intending to publicly dedicate any patentable subject matter.

Claims (2)

1. A lead removal apparatus comprising:
a shaft, wherein the shaft is flexible, the shaft having at least one outer surface, a proximal and a distal end, and wherein the shaft includes an inner lumen running from the proximal to the distal end to receive at least one of an implanted object and a mechanical traction device; and
a tissue dilating tip disposed adjacent to the distal end of the shaft, wherein the tissue dilating tip is configured to passively wedge into an area between a tissue growth and the implanted object, and wherein the at least one outer surface of the lead removal apparatus is configured to dilate the tissue growth about an area of the implanted object.
2-29. (canceled)
US14/877,683 2012-09-14 2015-10-07 Lead removal sleeve Abandoned US20160022303A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/877,683 US20160022303A1 (en) 2012-09-14 2015-10-07 Lead removal sleeve

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261701521P 2012-09-14 2012-09-14
US13/828,638 US20140081289A1 (en) 2012-09-14 2013-03-14 Lead removal sleeve
US14/877,683 US20160022303A1 (en) 2012-09-14 2015-10-07 Lead removal sleeve

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/828,638 Continuation US20140081289A1 (en) 2012-09-14 2013-03-14 Lead removal sleeve

Publications (1)

Publication Number Publication Date
US20160022303A1 true US20160022303A1 (en) 2016-01-28

Family

ID=50275252

Family Applications (13)

Application Number Title Priority Date Filing Date
US13/828,231 Active 2036-08-26 US9949753B2 (en) 2012-09-14 2013-03-14 Tissue slitting methods and systems
US13/828,638 Abandoned US20140081289A1 (en) 2012-09-14 2013-03-14 Lead removal sleeve
US13/828,383 Active US10531891B2 (en) 2012-09-14 2013-03-14 Tissue slitting methods and systems
US13/828,536 Active 2034-05-08 US9724122B2 (en) 2012-09-14 2013-03-14 Expandable lead jacket
US13/828,441 Active 2033-07-19 US9763692B2 (en) 2012-09-14 2013-03-14 Tissue slitting methods and systems
US13/828,310 Active 2034-06-22 US9413896B2 (en) 2012-09-14 2013-03-14 Tissue slitting methods and systems
US14/877,683 Abandoned US20160022303A1 (en) 2012-09-14 2015-10-07 Lead removal sleeve
US15/229,873 Active 2033-11-29 US10368900B2 (en) 2012-09-14 2016-08-05 Tissue slitting methods and systems
US15/621,728 Abandoned US20170340346A1 (en) 2012-09-14 2017-06-13 Expandable lead jacket
US15/666,338 Abandoned US20170325835A1 (en) 2012-09-14 2017-08-01 Tissue slitting methods and systems
US15/940,548 Active 2033-11-02 US11596435B2 (en) 2012-09-14 2018-03-29 Tissue slitting methods and systems
US16/703,566 Abandoned US20200107854A1 (en) 2012-09-14 2019-12-04 Tissue slitting methods and systems
US18/107,072 Pending US20230181215A1 (en) 2012-09-14 2023-02-08 Tissue slitting methods and systems

Family Applications Before (6)

Application Number Title Priority Date Filing Date
US13/828,231 Active 2036-08-26 US9949753B2 (en) 2012-09-14 2013-03-14 Tissue slitting methods and systems
US13/828,638 Abandoned US20140081289A1 (en) 2012-09-14 2013-03-14 Lead removal sleeve
US13/828,383 Active US10531891B2 (en) 2012-09-14 2013-03-14 Tissue slitting methods and systems
US13/828,536 Active 2034-05-08 US9724122B2 (en) 2012-09-14 2013-03-14 Expandable lead jacket
US13/828,441 Active 2033-07-19 US9763692B2 (en) 2012-09-14 2013-03-14 Tissue slitting methods and systems
US13/828,310 Active 2034-06-22 US9413896B2 (en) 2012-09-14 2013-03-14 Tissue slitting methods and systems

Family Applications After (6)

Application Number Title Priority Date Filing Date
US15/229,873 Active 2033-11-29 US10368900B2 (en) 2012-09-14 2016-08-05 Tissue slitting methods and systems
US15/621,728 Abandoned US20170340346A1 (en) 2012-09-14 2017-06-13 Expandable lead jacket
US15/666,338 Abandoned US20170325835A1 (en) 2012-09-14 2017-08-01 Tissue slitting methods and systems
US15/940,548 Active 2033-11-02 US11596435B2 (en) 2012-09-14 2018-03-29 Tissue slitting methods and systems
US16/703,566 Abandoned US20200107854A1 (en) 2012-09-14 2019-12-04 Tissue slitting methods and systems
US18/107,072 Pending US20230181215A1 (en) 2012-09-14 2023-02-08 Tissue slitting methods and systems

Country Status (3)

Country Link
US (13) US9949753B2 (en)
EP (3) EP2895087B1 (en)
WO (2) WO2014043329A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017217998A1 (en) * 2016-06-16 2017-12-21 Datta Subhajit Dual vacuum device for medical fixture placement including thoracoscopic left ventricular lead placement
US10368900B2 (en) 2012-09-14 2019-08-06 The Spectranetics Corporation Tissue slitting methods and systems
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
US10933247B2 (en) 2017-08-21 2021-03-02 MRM MedTech, LLC Lead with integrated features to facilitate extraction and associated methods of extraction
US11865334B2 (en) 2017-08-21 2024-01-09 MRM MedTech, LLC Lead with integrated feature including a low friction component to facilitate extraction and associated methods of extraction

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013021463A2 (en) 2011-02-24 2016-11-01 Eximo Medical Ltd tissue resection hybrid catheter
US9283040B2 (en) * 2013-03-13 2016-03-15 The Spectranetics Corporation Device and method of ablative cutting with helical tip
CN111317565B (en) 2014-05-18 2023-05-09 爱克斯莫医疗有限公司 System for tissue ablation using pulsed lasers
US20170105762A1 (en) * 2015-10-15 2017-04-20 Medtronic Advanced Energy Llc Lead extraction
DE102016003295B3 (en) * 2016-03-04 2017-05-11 Technische Universität Ilmenau Adaptive electrode carrier, its use and method for its insertion
EP3436137B1 (en) * 2016-03-31 2021-12-15 Cardiac Pacemakers, Inc. Extraction devices configued to extract chronically implanted medical devices
CN109414292A (en) 2016-05-05 2019-03-01 爱克斯莫医疗有限公司 Device and method for cutting off and/or melting unwanted tissue
CN106943176A (en) * 2017-04-28 2017-07-14 卞晓明 Double-jacket tube knife Harvesting of Great Saphenous Vein device
CN110573099B (en) 2017-05-03 2023-01-03 美敦力瓦斯科尔勒公司 Tissue removal catheter
US11690645B2 (en) 2017-05-03 2023-07-04 Medtronic Vascular, Inc. Tissue-removing catheter
US10441449B1 (en) 2018-05-30 2019-10-15 Vesper Medical, Inc. Rotary handle stent delivery system and method
US10449073B1 (en) 2018-09-18 2019-10-22 Vesper Medical, Inc. Rotary handle stent delivery system and method
US11357534B2 (en) 2018-11-16 2022-06-14 Medtronic Vascular, Inc. Catheter
US20220079614A1 (en) * 2019-01-21 2022-03-17 Koninklijke Philips N.V. Vascular treatment systems and devices including intravascular imaging capabilities
US11819236B2 (en) 2019-05-17 2023-11-21 Medtronic Vascular, Inc. Tissue-removing catheter
CA3147413A1 (en) 2019-07-15 2021-01-21 Ancora Heart, Inc. Devices and methods for tether cutting
US11678908B2 (en) 2019-09-06 2023-06-20 Koninklijke Philips N.V. Traction applying devices for lead removal systems
WO2021136210A1 (en) * 2019-12-30 2021-07-08 杭州诺茂医疗科技有限公司 Removal device
WO2021136203A1 (en) * 2019-12-30 2021-07-08 杭州诺茂医疗科技有限公司 Lead extraction apparatus
US11219541B2 (en) 2020-05-21 2022-01-11 Vesper Medical, Inc. Wheel lock for thumbwheel actuated device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228052B1 (en) * 1996-02-29 2001-05-08 Medtronic Inc. Dilator for introducer system having injection port
US6419674B1 (en) * 1996-11-27 2002-07-16 Cook Vascular Incorporated Radio frequency dilator sheath
US20080154293A1 (en) * 2006-12-22 2008-06-26 The Spectranetics Corporation Retractable Separating Systems and Methods
US20080154296A1 (en) * 2006-12-22 2008-06-26 The Spectranetics Corporation Tissue Separating Systems and Methods

Family Cites Families (513)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1663761A (en) 1927-02-07 1928-03-27 George A Johnson Surgical instrument
US3400708A (en) 1965-11-24 1968-09-10 Robert A. Scheidt Cytologic endocrine evaluation device
US3521640A (en) 1967-12-07 1970-07-28 Jane T Carey Surgical apparatus for use with a diseased lung or the like and related method
GB1235321A (en) 1968-01-30 1971-06-09 Nat Res Dev Improvements in or relating to drills for clearing obstructions
US3805382A (en) 1971-06-17 1974-04-23 Ajax Tool Works Inc Coaxial cable slitter
US3831274A (en) * 1973-12-28 1974-08-27 Scott & Fetzer Co Jacket stripper
US3858577A (en) 1974-04-05 1975-01-07 Univ Southern California Fiber optic laser light delivery system
DE2540299C3 (en) 1975-09-10 1978-03-02 Heinrich 6301 Biebertal Hofmann Wire scissors, in particular for cutting electrical circuit wires
US4203444A (en) 1977-11-07 1980-05-20 Dyonics, Inc. Surgical instrument suitable for closed surgery such as of the knee
US4246902A (en) 1978-03-10 1981-01-27 Miguel Martinez Surgical cutting instrument
US4274414A (en) 1979-02-21 1981-06-23 Dyonics, Inc. Surgical instrument
US4559927A (en) 1979-11-26 1985-12-24 Thomas J. Fogarty Endarterectomy apparatus and process
US4311138A (en) 1980-03-10 1982-01-19 Sugarman Edward D Illuminated hypodermic needle
US4517977A (en) 1981-07-24 1985-05-21 Unisearch Limited Co-axial tube surgical infusion/suction cutter tip
US5041108A (en) 1981-12-11 1991-08-20 Pillco Limited Partnership Method for laser treatment of body lumens
US4567882A (en) * 1982-12-06 1986-02-04 Vanderbilt University Method for locating the illuminated tip of an endotracheal tube
US4576162A (en) 1983-03-30 1986-03-18 Mccorkle Charles E Apparatus and method for separation of scar tissue in venous pathway
US4471777A (en) 1983-03-30 1984-09-18 Mccorkle Jr Charles E Endocardial lead extraction apparatus and method
US4582056A (en) 1983-03-30 1986-04-15 Mccorkle Jr Charles E Endocardial lead extraction apparatus and method
US4598710A (en) 1984-01-20 1986-07-08 Urban Engineering Company, Inc. Surgical instrument and method of making same
US4627436A (en) 1984-03-01 1986-12-09 Innoventions Biomedical Inc. Angioplasty catheter and method for use thereof
US4754755A (en) 1984-05-14 1988-07-05 Husted Royce Hill Catheter with a rotary blade
US4566438A (en) 1984-10-05 1986-01-28 Liese Grover J Fiber-optic stylet for needle tip localization
US4662869A (en) 1984-11-19 1987-05-05 Wright Kenneth W Precision intraocular apparatus
US5989243A (en) 1984-12-07 1999-11-23 Advanced Interventional Systems, Inc. Excimer laser angioplasty system
US4641912A (en) * 1984-12-07 1987-02-10 Tsvi Goldenberg Excimer laser delivery system, angioscope and angioplasty system incorporating the delivery system and angioscope
US5470330A (en) 1984-12-07 1995-11-28 Advanced Interventional Systems, Inc. Guidance and delivery system for high-energy pulsed laser light
US4718417A (en) * 1985-03-22 1988-01-12 Massachusetts Institute Of Technology Visible fluorescence spectral diagnostic for laser angiosurgery
US20020045811A1 (en) 1985-03-22 2002-04-18 Carter Kittrell Laser ablation process and apparatus
ATE111711T1 (en) 1985-03-22 1994-10-15 Massachusetts Inst Technology CATHETER FOR LASER ANGIO SURGERY.
US4862886A (en) * 1985-05-08 1989-09-05 Summit Technology Inc. Laser angioplasty
US4917084A (en) 1985-07-31 1990-04-17 C. R. Bard, Inc. Infrared laser catheter system
US4674502A (en) 1985-09-27 1987-06-23 Coopervision, Inc. Intraocular surgical instrument
US4646738A (en) 1985-12-05 1987-03-03 Concept, Inc. Rotary surgical tool
US4842578A (en) * 1986-03-12 1989-06-27 Dyonics, Inc. Surgical abrading instrument
US4729763A (en) 1986-06-06 1988-03-08 Henrie Rodney A Catheter for removing occlusive material
US4767403A (en) 1987-02-09 1988-08-30 The Boc Group, Inc. Positive pulse device and system
US4844062A (en) * 1987-10-23 1989-07-04 Spectranetics Corporation Rotating fiberoptic laser catheter assembly with eccentric lumen
US5207683A (en) 1988-11-09 1993-05-04 Cook Pacemaker Corporation Apparatus for removing an elongated structure implanted in biological tissue
US5011482A (en) 1989-01-17 1991-04-30 Cook Pacemaker Corporation Apparatus for removing an elongated structure implanted in biological tissue
US6136005A (en) 1988-11-09 2000-10-24 Cook Pacemaker Corporation Apparatus for removing a coiled structure implanted in biological tissue, having expandable means including a laterally deflectable member
US4988347A (en) 1988-11-09 1991-01-29 Cook Pacemaker Corporation Method and apparatus for separating a coiled structure from biological tissue
US4943289A (en) 1989-05-03 1990-07-24 Cook Pacemaker Corporation Apparatus for removing an elongated structure implanted in biological tissue
US5507751A (en) 1988-11-09 1996-04-16 Cook Pacemaker Corporation Locally flexible dilator sheath
US5013310A (en) 1988-11-09 1991-05-07 Cook Pacemaker Corporation Method and apparatus for removing an implanted pacemaker lead
EP0368512A3 (en) 1988-11-10 1990-08-08 Premier Laser Systems, Inc. Multiwavelength medical laser system
US5697936A (en) 1988-11-10 1997-12-16 Cook Pacemaker Corporation Device for removing an elongated structure implanted in biological tissue
JP2681073B2 (en) 1989-01-17 1997-11-19 則雄 大工園 Laser light emitting probe and manufacturing method thereof
JP2779825B2 (en) 1989-02-15 1998-07-23 則雄 大工園 Laser light emitting device
US4911148A (en) 1989-03-14 1990-03-27 Intramed Laboratories, Inc. Deflectable-end endoscope with detachable flexible shaft assembly
US4997424A (en) 1989-04-05 1991-03-05 Medamicus, Inc. Catheter introducer and introducer slitter
US5148599A (en) 1989-05-01 1992-09-22 Purcell Thomas L Mold extractor and method
ATE159647T1 (en) 1989-07-31 1997-11-15 Israel Barken ULTRASONIC LASER SURGICAL DEVICE
JP2882818B2 (en) 1989-09-08 1999-04-12 株式会社エス・エル・ティ・ジャパン Laser irradiation equipment
US5114403A (en) * 1989-09-15 1992-05-19 Eclipse Surgical Technologies, Inc. Catheter torque mechanism
DE69030262T2 (en) 1989-10-25 1997-07-10 Jack Murray Dodick SURGICAL INSTRUMENT WITH CONVERTER FOR INPUT PERFORMANCE
US5031634A (en) 1990-01-19 1991-07-16 Beth Israel Hospital Assoc., Inc. Adjustable biopsy needle-guide device
US5916210A (en) 1990-01-26 1999-06-29 Intraluminal Therapeutics, Inc. Catheter for laser treatment of atherosclerotic plaque and other tissue abnormalities
US5152744A (en) 1990-02-07 1992-10-06 Smith & Nephew Dyonics Surgical instrument
US5100424A (en) 1990-05-21 1992-03-31 Cardiovascular Imaging Systems, Inc. Intravascular catheter having combined imaging abrasion head
US5275609A (en) 1990-06-22 1994-01-04 Vance Products Incorporated Surgical cutting instrument
JPH06114070A (en) 1990-06-22 1994-04-26 Vance Prod Inc Tissue abscission device for surgery
US5188634A (en) * 1990-07-13 1993-02-23 Trimedyne, Inc. Rotatable laser probe with beveled tip
US5030207A (en) * 1990-11-02 1991-07-09 Becton, Dickinson And Company Instantaneous vein entry indicator for intravenous needle
DE4038773A1 (en) 1990-12-05 1992-06-11 Klaas Dieter Ultrasonic phako probe for cataract operation - has hollow suction needle connected to ultrasonic source and withdrawing natural eye lens tissue
US5201316A (en) 1991-03-18 1993-04-13 Cardiovascular Imaging Systems, Inc. Guide wire receptacle for catheters having rigid housings
US6485413B1 (en) 1991-04-29 2002-11-26 The General Hospital Corporation Methods and apparatus for forward-directed optical scanning instruments
US5250045A (en) 1991-06-11 1993-10-05 The Spectranetics Corporation Optical fiber catheter with spaced optical fiber
US5263928A (en) 1991-06-14 1993-11-23 Baxter International Inc. Catheter and endoscope assembly and method of use
US5186634A (en) 1991-12-20 1993-02-16 John Fluke Mfg. Co., Inc. Electrical contact having spring-biased tabs for mounting to a circuit board
US5230334A (en) 1992-01-22 1993-07-27 Summit Technology, Inc. Method and apparatus for generating localized hyperthermia
US5353786A (en) 1992-01-24 1994-10-11 Wilk Peter J Surgical lighting method
CA2103252A1 (en) 1992-03-18 1993-09-19 Dan J. Hammersmark Fiber optic catheter with twistable tip
US5620414A (en) * 1992-06-30 1997-04-15 Campbell, Jr.; Robert M. Apparatus and method for effecting surgical incision through use of a fluid jet
US5383199A (en) 1992-07-02 1995-01-17 Advanced Interventional Systems, Inc. Apparatus and method for optically controlling the output energy of a pulsed laser source
AU4854393A (en) 1992-09-11 1994-04-12 Advanced Surgical, Inc. Self-introducing infusion catheter
US5460182A (en) 1992-09-14 1995-10-24 Sextant Medical Corporation Tissue penetrating apparatus and methods
US5373840A (en) 1992-10-02 1994-12-20 Knighton; David R. Endoscope and method for vein removal
US5522795A (en) * 1993-01-25 1996-06-04 United States Surgical Corporation Endoscopic swab device
US5396902A (en) 1993-02-03 1995-03-14 Medtronic, Inc. Steerable stylet and manipulative handle assembly
US5423330A (en) 1993-03-10 1995-06-13 The University Of Miami Capsule suction punch instrument and method of use
US5468238A (en) 1993-06-11 1995-11-21 Ethicon, Inc. Endoscopic laser instrument
US5456680A (en) 1993-09-14 1995-10-10 Spectranetics Corp Fiber optic catheter with shortened guide wire lumen
US5573008A (en) 1993-10-29 1996-11-12 Boston Scientific Corporation Multiple biopsy sampling coring device
SE9303122D0 (en) 1993-09-24 1993-09-24 Siemens Elema Ab Device for explantation of an electrode device
US5423806A (en) * 1993-10-01 1995-06-13 Medtronic, Inc. Laser extractor for an implanted object
US5358487A (en) 1993-10-15 1994-10-25 Cordis Corporation Frangible balloon catheter
US5507760A (en) * 1993-11-09 1996-04-16 Devices For Vascular Intervention, Inc. Cutter device
US5487392A (en) 1993-11-15 1996-01-30 Haaga; John R. Biopxy system with hemostatic insert
US5484433A (en) * 1993-12-30 1996-01-16 The Spectranetics Corporation Tissue ablating device having a deflectable ablation area and method of using same
US5395328A (en) 1994-01-19 1995-03-07 Daig Corporation Steerable catheter tip having an X-shaped lumen
US5466234A (en) 1994-01-31 1995-11-14 Trimedyne, Inc. Expandable laser catheter
US5489291A (en) * 1994-02-23 1996-02-06 Wiley; Roy C. Apparatus for removing tissue during surgical procedures
US5667472A (en) 1994-03-18 1997-09-16 Clarus Medical Systems, Inc. Surgical instrument and method for use with a viewing system
US5649547A (en) 1994-03-24 1997-07-22 Biopsys Medical, Inc. Methods and devices for automated biopsy and collection of soft tissue
US5573531A (en) 1994-06-20 1996-11-12 Gregory; Kenton W. Fluid core laser angioscope
US5665051A (en) 1994-08-12 1997-09-09 Imagyn Medical Endoscope with axially movable optical fiber guide to compensate changes in length
US8025661B2 (en) 1994-09-09 2011-09-27 Cardiofocus, Inc. Coaxial catheter instruments for ablation with radiant energy
US5569284A (en) 1994-09-23 1996-10-29 United States Surgical Corporation Morcellator
US6071274A (en) 1996-12-19 2000-06-06 Ep Technologies, Inc. Loop structures for supporting multiple electrode elements
US5562694A (en) 1994-10-11 1996-10-08 Lasersurge, Inc. Morcellator
AU701424B2 (en) * 1994-10-24 1999-01-28 Smith & Nephew, Inc. Hollow surgical cutter with apertured flutes
US6027450A (en) 1994-12-30 2000-02-22 Devices For Vascular Intervention Treating a totally or near totally occluded lumen
US5814044A (en) 1995-02-10 1998-09-29 Enable Medical Corporation Apparatus and method for morselating and removing tissue from a patient
US5873886A (en) 1995-04-04 1999-02-23 United States Surgical Corporation Surgical cutting apparatus
US5879365A (en) 1995-04-04 1999-03-09 United States Surgical Corporation Surgical cutting apparatus
US5651781A (en) 1995-04-20 1997-07-29 Grace-Wells Technology Partners No. 1, L.P. Surgical cutting instrument
US5620451A (en) 1995-04-25 1997-04-15 Intermedics, Inc. Lead extraction system for transvenous defibrillation leads and for endocardial pacing leads
US5707389A (en) 1995-06-07 1998-01-13 Baxter International Inc. Side branch occlusion catheter device having integrated endoscope for performing endoscopically visualized occlusion of the side branches of an anatomical passageway
US5735847A (en) * 1995-08-15 1998-04-07 Zomed International, Inc. Multiple antenna ablation apparatus and method with cooling element
US6669685B1 (en) 1997-11-06 2003-12-30 Biolase Technology, Inc. Tissue remover and method
US5947958A (en) 1995-09-14 1999-09-07 Conceptus, Inc. Radiation-transmitting sheath and methods for its use
EP0955933B1 (en) 1995-10-13 2009-08-26 Medtronic Vascular, Inc. A device for interstitial transvascular intervention
DE69633411T2 (en) 1995-10-13 2005-10-20 Transvascular, Inc., Menlo Park METHOD AND DEVICE FOR PREVENTING ARTERIAL ATTRACTIONS AND / OR FOR CARRYING OUT OTHER TRANSVASCULAR INTERVENTIONS
US5700270A (en) 1995-10-20 1997-12-23 United States Surgical Corporation Surgical clip applier
US5916149A (en) 1995-10-25 1999-06-29 Ryan, Jr.; Edwin H. Shielded illumination device for ophthalmic surgery and the like
US5825958A (en) 1996-01-25 1998-10-20 Pharos Optics, Inc. Fiber optic delivery system for infrared lasers
US5863294A (en) 1996-01-26 1999-01-26 Femrx, Inc. Folded-end surgical tubular cutter and method for fabrication
US6099537A (en) 1996-02-26 2000-08-08 Olympus Optical Co., Ltd. Medical treatment instrument
US5682199A (en) 1996-03-28 1997-10-28 Jedmed Instrument Company Video endoscope with interchangeable endoscope heads
US5725523A (en) 1996-03-29 1998-03-10 Mueller; Richard L. Lateral-and posterior-aspect method and apparatus for laser-assisted transmyocardial revascularization and other surgical applications
US6258083B1 (en) 1996-03-29 2001-07-10 Eclipse Surgical Technologies, Inc. Viewing surgical scope for minimally invasive procedures
US6027497A (en) 1996-03-29 2000-02-22 Eclipse Surgical Technologies, Inc. TMR energy delivery system
AU5279898A (en) 1996-03-29 1998-03-26 Eclipse Surgical Technologies, Inc. Minimally invasive method and apparatus for forming revascularization channels
US5766164A (en) 1996-07-03 1998-06-16 Eclipse Surgical Technologies, Inc. Contiguous, branched transmyocardial revascularization (TMR) channel, method and device
US6019756A (en) 1996-04-05 2000-02-01 Eclipse Surgical Technologies, Inc. Laser device for transmyocardial revascularization procedures
US5782823A (en) 1996-04-05 1998-07-21 Eclipse Surgical Technologies, Inc. Laser device for transmyocardial revascularization procedures including means for enabling a formation of a pilot hole in the epicardium
US6152918A (en) 1996-04-05 2000-11-28 Eclipse Surgical Technologies, Inc. Laser device with auto-piercing tip for myocardial revascularization procedures
US6419673B1 (en) 1996-05-06 2002-07-16 Stuart Edwards Ablation of rectal and other internal body structures
US5980545A (en) 1996-05-13 1999-11-09 United States Surgical Corporation Coring device and method
US6152909A (en) 1996-05-20 2000-11-28 Percusurge, Inc. Aspiration system and method
US6652480B1 (en) 1997-03-06 2003-11-25 Medtronic Ave., Inc. Methods for reducing distal embolization
US6022336A (en) 1996-05-20 2000-02-08 Percusurge, Inc. Catheter system for emboli containment
US6398776B1 (en) 1996-06-03 2002-06-04 Terumo Kabushiki Kaisha Tubular medical device
US5824026A (en) * 1996-06-12 1998-10-20 The Spectranetics Corporation Catheter for delivery of electric energy and a process for manufacturing same
CA2207570A1 (en) 1996-06-13 1997-12-13 Eclipse Surgical Technologies, Inc. Intraoperative myocardial device and stimulation procedure
US6352535B1 (en) 1997-09-25 2002-03-05 Nanoptics, Inc. Method and a device for electro microsurgery in a physiological liquid environment
US6719755B2 (en) 1996-10-22 2004-04-13 Epicor Medical, Inc. Methods and devices for ablation
US5807399A (en) 1996-10-23 1998-09-15 Medtronic, Inc. Method for removal of chronically implanted leads and leads optimized for use therewith
US5746738A (en) 1996-11-20 1998-05-05 Cleary & Oxford Associates Laser surgical device
US5899915A (en) 1996-12-02 1999-05-04 Angiotrax, Inc. Apparatus and method for intraoperatively performing surgery
US6120520A (en) 1997-05-27 2000-09-19 Angiotrax, Inc. Apparatus and methods for stimulating revascularization and/or tissue growth
US5910150A (en) 1996-12-02 1999-06-08 Angiotrax, Inc. Apparatus for performing surgery
US6051008A (en) 1996-12-02 2000-04-18 Angiotrax, Inc. Apparatus having stabilization members for percutaneously performing surgery and methods of use
US6102926A (en) 1996-12-02 2000-08-15 Angiotrax, Inc. Apparatus for percutaneously performing myocardial revascularization having means for sensing tissue parameters and methods of use
US6165188A (en) 1996-12-02 2000-12-26 Angiotrax, Inc. Apparatus for percutaneously performing myocardial revascularization having controlled cutting depth and methods of use
US6010476A (en) 1996-12-02 2000-01-04 Angiotrax, Inc. Apparatus for performing transmyocardial revascularization
US5766194A (en) * 1996-12-23 1998-06-16 Georgia Skin And Cancer Clinic, Pc Surgical apparatus for tissue removal
US5970982A (en) * 1997-02-20 1999-10-26 Perkins; Rodney C. Minimally invasive biological vessel harvesting method
AU6688398A (en) 1997-03-06 1998-09-22 Percusurge, Inc. Intravascular aspiration system
US5876373A (en) 1997-04-04 1999-03-02 Eclipse Surgical Technologies, Inc. Steerable catheter
US5893862A (en) 1997-04-10 1999-04-13 Pratt; Arthur William Surgical apparatus
US6156049A (en) 1997-04-11 2000-12-05 Coherent Inc. Method and apparatus for transurethral resection of the prostate
US6117128A (en) 1997-04-30 2000-09-12 Kenton W. Gregory Energy delivery catheter and method for the use thereof
US6855143B2 (en) * 1997-06-13 2005-02-15 Arthrocare Corporation Electrosurgical systems and methods for recanalization of occluded body lumens
US5951543A (en) * 1997-06-30 1999-09-14 Clinicon Corporation Delivery system and method for surgical laser
US6869431B2 (en) * 1997-07-08 2005-03-22 Atrionix, Inc. Medical device with sensor cooperating with expandable member
US6013072A (en) 1997-07-09 2000-01-11 Intraluminal Therapeutics, Inc. Systems and methods for steering a catheter through body tissue
US5906611A (en) 1997-07-28 1999-05-25 Dodick; Jack Murray Surgical instrument with laser target
US6039748A (en) 1997-08-05 2000-03-21 Femrx, Inc. Disposable laparoscopic morcellator
US6050955A (en) 1997-09-19 2000-04-18 United States Surgical Corporation Biopsy apparatus and method
US6190352B1 (en) 1997-10-01 2001-02-20 Boston Scientific Corporation Guidewire compatible port and method for inserting same
US5972012A (en) 1997-10-17 1999-10-26 Angiotrax, Inc. Cutting apparatus having articulable tip
DE19747046C2 (en) 1997-10-24 2003-01-02 Zeiss Carl Meditec Ag Medical handpiece
US6162214A (en) 1997-10-30 2000-12-19 Eclipse Surgical Technologies, Inc. Corning device for myocardial revascularization
DE19748579C2 (en) 1997-11-04 2000-02-03 Storz Karl Gmbh & Co Endoscopic instrument
US5980515A (en) 1997-12-19 1999-11-09 Irvine Biomedical, Inc. Devices and methods for lead extraction
US6368318B1 (en) 1998-01-23 2002-04-09 The Regents Of The University Of California Opto-acoustic recanilization delivery system
DE19806718A1 (en) 1998-02-18 1999-08-26 Storz Endoskop Gmbh System for treating of body tissue using ultrasound with generator and unit transmitting ultrasound on tissue and hollow probe
US6193673B1 (en) 1998-02-20 2001-02-27 United States Surgical Corporation Biopsy instrument driver apparatus
US6053923A (en) * 1998-03-17 2000-04-25 Arthrotek, Inc. Method and apparatus for abrading tissue
US6500182B2 (en) 1998-03-27 2002-12-31 Cook Urological, Incorporated Minimally-invasive medical retrieval device
AU3363999A (en) 1998-03-27 1999-10-18 General Hospital Corporation, The Method and apparatus for the selective targeting of lipid-rich tissues
US6440138B1 (en) 1998-04-06 2002-08-27 Kyphon Inc. Structures and methods for creating cavities in interior body regions
US6290668B1 (en) 1998-04-30 2001-09-18 Kenton W. Gregory Light delivery catheter and methods for the use thereof
IL124445A0 (en) 1998-05-12 1998-12-06 Med En Ltd Device and method for evacuating refuse from tissues of the body
US6579270B2 (en) * 1998-06-04 2003-06-17 Alcon Manufacturing, Ltd. Liquefracture handpiece tip
US6296639B1 (en) 1999-02-12 2001-10-02 Novacept Apparatuses and methods for interstitial tissue removal
US6547779B2 (en) 1998-07-22 2003-04-15 Endovasix, Inc. Flexible flow apparatus and method for the disruption of occlusions
US6463334B1 (en) 1998-11-02 2002-10-08 Cardiac Pacemakers, Inc. Extendable and retractable lead
US6139543A (en) 1998-07-22 2000-10-31 Endovasix, Inc. Flow apparatus for the disruption of occlusions
US6210400B1 (en) 1998-07-22 2001-04-03 Endovasix, Inc. Flexible flow apparatus and method for the disruption of occlusions
US6080175A (en) 1998-07-29 2000-06-27 Corvascular, Inc. Surgical cutting instrument and method of use
US6106515A (en) * 1998-08-13 2000-08-22 Intraluminal Therapeutics, Inc. Expandable laser catheter
US6620180B1 (en) 1998-09-09 2003-09-16 Medtronic Xomed, Inc. Powered laryngeal cutting blade
US6033402A (en) 1998-09-28 2000-03-07 Irvine Biomedical, Inc. Ablation device for lead extraction and methods thereof
US6241692B1 (en) 1998-10-06 2001-06-05 Irvine Biomedical, Inc. Ultrasonic ablation device and methods for lead extraction
US6083237A (en) 1998-10-23 2000-07-04 Ethico Endo-Surgery, Inc. Biopsy instrument with tissue penetrating spiral
US20010047183A1 (en) 2000-04-05 2001-11-29 Salvatore Privitera Surgical device for the collection of soft tissue
US6123718A (en) 1998-11-02 2000-09-26 Polymerex Medical Corp. Balloon catheter
US6436054B1 (en) 1998-11-25 2002-08-20 United States Surgical Corporation Biopsy system
JP2001353176A (en) 2000-04-13 2001-12-25 Nikon Corp Laser treatment apparatus
US6228076B1 (en) 1999-01-09 2001-05-08 Intraluminal Therapeutics, Inc. System and method for controlling tissue ablation
US6203537B1 (en) 1999-02-04 2001-03-20 Sorin Adrian Laser-driven acoustic ablation catheter
JP4310049B2 (en) 1999-02-19 2009-08-05 ボストン サイエンティフィック リミテッド Laser lithotripsy device using suction
US6432119B1 (en) 1999-03-17 2002-08-13 Angiotrax, Inc. Apparatus and methods for performing percutaneous myocardial revascularization and stimulating angiogenesis using autologous materials
US6893450B2 (en) 1999-03-26 2005-05-17 Cook Urological Incorporated Minimally-invasive medical retrieval device
US8428747B2 (en) 1999-04-05 2013-04-23 The Spectranetics Corp. Lead locking device and method
US6167315A (en) 1999-04-05 2000-12-26 Spectranetics Corporation Lead locking device and method
US6772014B2 (en) 2000-12-04 2004-08-03 The Spectranetics Corporation Lead locking device and method
EP1092449A1 (en) 1999-04-30 2001-04-18 Usaminanotechnology, Inc. Catheter and guide wire
US6716233B1 (en) 1999-06-02 2004-04-06 Power Medical Interventions, Inc. Electromechanical driver and remote surgical instrument attachment having computer assisted control capabilities
US7695485B2 (en) 2001-11-30 2010-04-13 Power Medical Interventions, Llc Surgical device
US7951071B2 (en) 1999-06-02 2011-05-31 Tyco Healthcare Group Lp Moisture-detecting shaft for use with an electro-mechanical surgical device
US8025199B2 (en) 2004-02-23 2011-09-27 Tyco Healthcare Group Lp Surgical cutting and stapling device
US6264087B1 (en) 1999-07-12 2001-07-24 Powermed, Inc. Expanding parallel jaw device for use with an electromechanical driver device
US6565583B1 (en) 1999-07-08 2003-05-20 Acumen Vascular, Inc. Endarterectomy apparatus and method
US6235044B1 (en) 1999-08-04 2001-05-22 Scimed Life Systems, Inc. Percutaneous catheter and guidewire for filtering during ablation of mycardial or vascular tissue
US7526342B2 (en) 1999-08-10 2009-04-28 Maquet Cardiovascular Llc Apparatus for endoscopic cardiac mapping and lead placement
US7597698B2 (en) 1999-08-10 2009-10-06 Maquet Cardiovascular Llc Apparatus and method for endoscopic encirclement of pulmonary veins for epicardial ablation
US6706052B1 (en) 1999-08-10 2004-03-16 Origin Medsystems, Inc. Longitudinal dilator and method
US7288096B2 (en) 2003-01-17 2007-10-30 Origin Medsystems, Inc. Apparatus for placement of cardiac defibrillator and pacer
US20040102804A1 (en) 1999-08-10 2004-05-27 Chin Albert K. Apparatus and methods for endoscopic surgical procedures
US7264587B2 (en) 1999-08-10 2007-09-04 Origin Medsystems, Inc. Endoscopic subxiphoid surgical procedures
US7398781B1 (en) 1999-08-10 2008-07-15 Maquet Cardiovascular, Llc Method for subxiphoid endoscopic access
US20030187460A1 (en) 1999-08-10 2003-10-02 Chin Albert K. Methods and apparatus for endoscopic cardiac surgery
US6607547B1 (en) 1999-08-25 2003-08-19 Origin Medsystems, Inc. Longitudinal dilator and method
US20030187461A1 (en) 1999-08-10 2003-10-02 Chin Albert K. Releasable guide and method for endoscopic cardiac lead placement
US6569082B1 (en) 1999-08-10 2003-05-27 Origin Medsystems, Inc. Apparatus and methods for cardiac restraint
US20040147911A1 (en) 1999-08-25 2004-07-29 Cardiofocus, Inc. Surgical ablation instruments for forming an encircling lesion
US20060287574A1 (en) 1999-08-25 2006-12-21 Chin Albert K Longitudinal dilator
US6423051B1 (en) 1999-09-16 2002-07-23 Aaron V. Kaplan Methods and apparatus for pericardial access
JP2003509152A (en) 1999-09-24 2003-03-11 クック ウロロジカル インク. Embryo transfer catheter
US6368324B1 (en) 1999-09-24 2002-04-09 Medtronic Xomed, Inc. Powered surgical handpiece assemblies and handpiece adapter assemblies
US6398775B1 (en) 1999-10-21 2002-06-04 Pulmonx Apparatus and method for isolated lung access
US6395002B1 (en) 2000-01-18 2002-05-28 Alan G. Ellman Electrosurgical instrument for ear surgery
US7494484B2 (en) 1999-12-10 2009-02-24 Beck Robert C Method of removing particulate debris with an interventional device
US6428487B1 (en) 1999-12-17 2002-08-06 Ethicon Endo-Surgery, Inc. Surgical biopsy system with remote control for selecting an operational mode
US6575997B1 (en) 1999-12-23 2003-06-10 Endovascular Technologies, Inc. Embolic basket
US6660021B1 (en) 1999-12-23 2003-12-09 Advanced Cardiovascular Systems, Inc. Intravascular device and system
US6402771B1 (en) 1999-12-23 2002-06-11 Guidant Endovascular Solutions Snare
US9113936B2 (en) 1999-12-23 2015-08-25 Abbott Laboratories Snare
US6440125B1 (en) 2000-01-04 2002-08-27 Peter Rentrop Excimer laser catheter
US6989028B2 (en) 2000-01-31 2006-01-24 Edwards Lifesciences Ag Medical system and method for remodeling an extravascular tissue structure
US7296577B2 (en) 2000-01-31 2007-11-20 Edwards Lifescience Ag Transluminal mitral annuloplasty with active anchoring
US6402781B1 (en) 2000-01-31 2002-06-11 Mitralife Percutaneous mitral annuloplasty and cardiac reinforcement
US6575979B1 (en) 2000-02-16 2003-06-10 Axiamed, Inc. Method and apparatus for providing posterior or anterior trans-sacral access to spinal vertebrae
US8016855B2 (en) 2002-01-08 2011-09-13 Tyco Healthcare Group Lp Surgical device
WO2001066018A1 (en) 2000-03-03 2001-09-13 C. R. Bard, Inc. Endoscopic tissue apposition device with multiple suction ports
US6428539B1 (en) 2000-03-09 2002-08-06 Origin Medsystems, Inc. Apparatus and method for minimally invasive surgery using rotational cutting tool
US20010031981A1 (en) 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
NZ522128A (en) 2000-03-31 2003-08-29 Rita Medical Systems Inc Tissue biopsy and treatment apparatus and method
US7344546B2 (en) 2000-04-05 2008-03-18 Pathway Medical Technologies Intralumenal material removal using a cutting device for differential cutting
US20040243162A1 (en) 2000-04-05 2004-12-02 Pathway Medical Technologies, Inc. Interventional catheter assemblies and control systems
US8475484B2 (en) 2000-04-05 2013-07-02 Medrad, Inc. Liquid seal assembly for a rotating torque tube
AU2001253173B2 (en) 2000-04-05 2005-05-12 Boston Scientific Limited Intralumenal material removal systems and methods
US6565588B1 (en) 2000-04-05 2003-05-20 Pathway Medical Technologies, Inc. Intralumenal material removal using an expandable cutting device
US10092313B2 (en) 2000-04-05 2018-10-09 Boston Scientific Limited Medical sealed tubular structures
US6558382B2 (en) 2000-04-27 2003-05-06 Medtronic, Inc. Suction stabilized epicardial ablation devices
US6419684B1 (en) 2000-05-16 2002-07-16 Linvatec Corporation End-cutting shaver blade for axial resection
CA2409111C (en) 2000-05-17 2005-12-27 Cook Vascular Incorporated Lead removal apparatus
US6478777B1 (en) 2000-05-25 2002-11-12 Medtronic, Inc. Introducer system for medical electrical lead
AU2001279026B2 (en) 2000-07-25 2005-12-22 Angiodynamics, Inc. Apparatus for detecting and treating tumors using localized impedance measurement
US6712773B1 (en) 2000-09-11 2004-03-30 Tyco Healthcare Group Lp Biopsy system
DE10050648C2 (en) 2000-10-12 2003-11-06 Fraunhofer Ges Forschung Surgical instrument
US6602203B2 (en) 2000-10-13 2003-08-05 Ethicon Endo-Surgery, Inc. Remote thumbwheel for a surgical biopsy device
JP3996057B2 (en) 2000-11-27 2007-10-24 タイコ ヘルスケア グループ リミテッド パートナーシップ Tissue extractor
US6512959B1 (en) 2000-11-28 2003-01-28 Pacesetter, Inc. Double threaded stylet for extraction of leads with a threaded electrode
US6611710B2 (en) 2000-11-29 2003-08-26 Pacesetter, Inc. Double threaded stylet for extraction of leads with a threaded electrode
AU2002231074A1 (en) 2000-12-20 2002-07-01 Fox Hollow Technologies, Inc. Debulking catheter
US20020087151A1 (en) 2000-12-29 2002-07-04 Afx, Inc. Tissue ablation apparatus with a sliding ablation instrument and method
US6758806B2 (en) 2001-01-12 2004-07-06 Napoli, Llc Endoscopic devices and method of use
US6786898B2 (en) 2003-01-15 2004-09-07 Medtronic, Inc. Methods and tools for accessing an anatomic space
US8979801B2 (en) 2001-01-17 2015-03-17 Medtronic Vascular, Inc. Microcatheter devices and methods for targeted substance delivery
US6602241B2 (en) 2001-01-17 2003-08-05 Transvascular, Inc. Methods and apparatus for acute or chronic delivery of substances or apparatus to extravascular treatment sites
US7357794B2 (en) 2002-01-17 2008-04-15 Medtronic Vascular, Inc. Devices, systems and methods for acute or chronic delivery of substances or apparatus to extravascular treatment sites
US6810882B2 (en) 2001-01-30 2004-11-02 Ev3 Santa Rosa, Inc. Transluminal mitral annuloplasty
US7510576B2 (en) 2001-01-30 2009-03-31 Edwards Lifesciences Ag Transluminal mitral annuloplasty
US20020123785A1 (en) 2001-03-02 2002-09-05 Cardiac Pacemakers, Inc. Cardiac lead permitting easy extraction
US6673023B2 (en) 2001-03-23 2004-01-06 Stryker Puerto Rico Limited Micro-invasive breast biopsy device
WO2002083003A1 (en) 2001-04-11 2002-10-24 Clarke Dana S Tissue structure identification in advance of instrument
AT411013B (en) 2001-06-05 2003-09-25 Globe Technologies Ltd E VEIN STRIPPER
US7674245B2 (en) 2001-06-07 2010-03-09 Cardiac Pacemakers, Inc. Method and apparatus for an adjustable shape guide catheter
US6966906B2 (en) * 2001-06-08 2005-11-22 Joe Denton Brown Deflection mechanism for a surgical instrument, such as a laser delivery device and/or endoscope, and method of use
US6599296B1 (en) 2001-07-27 2003-07-29 Advanced Cardiovascular Systems, Inc. Ratcheting handle for intraluminal catheter systems
US7226459B2 (en) 2001-10-26 2007-06-05 Smith & Nephew, Inc. Reciprocating rotary arthroscopic surgical instrument
US20030092995A1 (en) 2001-11-13 2003-05-15 Medtronic, Inc. System and method of positioning implantable medical devices
CA2495911C (en) * 2001-11-21 2011-06-07 Hydrocision, Inc. Liquid jet surgical instruments incorporating channel openings aligned along the jet beam
US7399300B2 (en) 2001-12-04 2008-07-15 Endoscopic Technologies, Inc. Cardiac ablation devices and methods
US6706018B2 (en) 2001-12-04 2004-03-16 Cardiac Pacemakers, Inc. Adjustable length catheter assembly
EP1453432B1 (en) 2001-12-04 2012-08-01 Tyco Healthcare Group LP System and method for calibrating a surgical instrument
US6884240B1 (en) 2001-12-07 2005-04-26 Ronald Dykes Protection system for surgical instruments
US6979319B2 (en) 2001-12-31 2005-12-27 Cardiac Pacemakers, Inc. Telescoping guide catheter with peel-away outer sheath
AU2003225532A1 (en) 2002-01-24 2003-09-02 The Johns Hopkins University Methods and devices for percutaneous and surgical interventions
US8277411B2 (en) 2002-01-31 2012-10-02 Boston Scientific Scimed, Inc. Needle device
US7029460B2 (en) * 2002-02-15 2006-04-18 Medtronic, Inc. Slitting tool
US20040049208A1 (en) 2002-04-03 2004-03-11 Thomas Fogarty, M.D. Methods and systems for vein harvesting and fistula creation
US7191015B2 (en) 2002-04-11 2007-03-13 Medtronic Vascular, Inc. Devices and methods for transluminal or transthoracic interstitial electrode placement
US7306588B2 (en) 2002-04-22 2007-12-11 Trimedyne, Inc. Devices and methods for directed, interstitial ablation of tissue
US6802838B2 (en) 2002-04-22 2004-10-12 Trimedyne, Inc. Devices and methods for directed, interstitial ablation of tissue
EP1513440A2 (en) 2002-05-30 2005-03-16 The Board of Trustees of The Leland Stanford Junior University Apparatus and method for coronary sinus access
US8956280B2 (en) * 2002-05-30 2015-02-17 Intuitive Surgical Operations, Inc. Apparatus and methods for placing leads using direct visualization
WO2003105702A2 (en) 2002-06-14 2003-12-24 Power Medical Interventions, Inc. Surgical device
US7273478B2 (en) 2002-07-10 2007-09-25 Angiodynamics, Inc. Endovascular treatment device having a fiber tip spacer
US7449010B1 (en) 2002-07-15 2008-11-11 Motoya Hayase Material removal catheter and method
US7029467B2 (en) 2002-07-16 2006-04-18 Edwards Lifesciences Corporation Multiple lumen catheter having a soft tip
US6999809B2 (en) 2002-07-16 2006-02-14 Edwards Lifesciences Corporation Central venous catheter having a soft tip and fiber optics
US7151965B2 (en) 2002-07-19 2006-12-19 Oscor Inc. Device and method for delivering cardiac leads
JP2004049704A (en) 2002-07-23 2004-02-19 Nipro Corp Medical aspirator
US7993351B2 (en) 2002-07-24 2011-08-09 Pressure Products Medical Supplies, Inc. Telescopic introducer with a compound curvature for inducing alignment and method of using the same
US7396354B2 (en) 2002-08-05 2008-07-08 Rychnovsky Steven J Light delivery catheter
US7092765B2 (en) 2002-09-23 2006-08-15 Medtronic, Inc. Non-sheath based medical device delivery system
US7107105B2 (en) 2002-09-24 2006-09-12 Medtronic, Inc. Deployable medical lead fixation system and method
US8303511B2 (en) 2002-09-26 2012-11-06 Pacesetter, Inc. Implantable pressure transducer system optimized for reduced thrombosis effect
US7149587B2 (en) 2002-09-26 2006-12-12 Pacesetter, Inc. Cardiovascular anchoring device and method of deploying same
US6871085B2 (en) 2002-09-30 2005-03-22 Medtronic, Inc. Cardiac vein lead and guide catheter
US6962585B2 (en) 2002-11-22 2005-11-08 Poleo Jr Louis A Catherization system and method
US20040102783A1 (en) 2002-11-27 2004-05-27 Sutterlin Chester E. Powered Kerrison-like Rongeur system
US7158838B2 (en) 2003-01-31 2007-01-02 Medtronic, Inc. Arrangement for implanting a miniaturized cardiac lead having a fixation helix
US7651504B2 (en) 2003-02-05 2010-01-26 Cook Vascular Incorporated Device for removing an elongated structure implanted in biological tissue
US20040158236A1 (en) 2003-02-12 2004-08-12 Reinhardt Thyzel Surgical needle with laser target
US7252641B2 (en) 2003-02-25 2007-08-07 Ethicon Endo-Surgery, Inc. Method of operating a biopsy device
WO2004080507A2 (en) 2003-03-10 2004-09-23 Pathway Medical Technologies, Inc. Interventional catheters assemblies and control systems
US7077845B2 (en) * 2003-03-11 2006-07-18 Arthrex, Inc. Surgical abrader with suction port proximal to bearing
US7001369B2 (en) 2003-03-27 2006-02-21 Scimed Life Systems, Inc. Medical device
WO2005063113A1 (en) 2003-05-01 2005-07-14 Keio University Intravascular diagnostic or therapeutic apparatus using high-intensity pulsed light
US7544197B2 (en) 2003-05-06 2009-06-09 Greatbatch Ltd. Rotatable lead introducer
US20040225280A1 (en) 2003-05-09 2004-11-11 John Horrigan Laminated catheter comprising ultra high molecular weight high density polyethylene
US20040254534A1 (en) 2003-06-11 2004-12-16 Bjorkman Bradford A. Sliding connection assembly to facilitate lead stabilization
US7537592B2 (en) 2003-06-20 2009-05-26 Plc Medical Systems, Inc. Endovascular tissue removal device
US7563266B2 (en) 2003-06-30 2009-07-21 Depuy Products, Inc. Slide and kit for delivering implants
US7559941B2 (en) 2003-06-30 2009-07-14 Depuy Products, Inc. Instrument for delivery of implant
EP1646332B1 (en) 2003-07-18 2015-06-17 Edwards Lifesciences AG Remotely activated mitral annuloplasty system
US7204255B2 (en) 2003-07-28 2007-04-17 Plc Medical Systems, Inc. Endovascular tissue removal device
US7204824B2 (en) 2003-07-29 2007-04-17 Harry Moulis Medical liquid delivery device
CA2540470A1 (en) 2003-10-03 2005-04-14 Acumen Medical, Inc. Expandable guide sheath and apparatus and methods for making them
WO2005044124A1 (en) * 2003-10-30 2005-05-19 Medical Cv, Inc. Apparatus and method for laser treatment
US7238179B2 (en) 2003-10-30 2007-07-03 Medical Cv, Inc. Apparatus and method for guided ablation treatment
US7238180B2 (en) 2003-10-30 2007-07-03 Medicalcv Inc. Guided ablation with end-fire fiber
US7740626B2 (en) 2003-11-21 2010-06-22 Terumo Kabushiki Kaisha Laser induced liquid jet generating apparatus
US7637904B2 (en) 2003-12-19 2009-12-29 Vance Products Incorporated Catheter with snap on feature
US20050165288A1 (en) * 2004-01-27 2005-07-28 Scimed Life Systems, Inc. Systems and methods for treating breast tissue
US20050228452A1 (en) 2004-02-11 2005-10-13 Mourlas Nicholas J Steerable catheters and methods for using them
US7369901B1 (en) 2004-02-11 2008-05-06 Pacesetter, Inc. Myocardial lead and lead system
US20050197623A1 (en) 2004-02-17 2005-09-08 Leeflang Stephen A. Variable steerable catheters and methods for using them
US7331954B2 (en) 2004-04-08 2008-02-19 Omniguide, Inc. Photonic crystal fibers and medical systems including photonic crystal fibers
US20050251116A1 (en) 2004-05-05 2005-11-10 Minnow Medical, Llc Imaging and eccentric atherosclerotic material laser remodeling and/or ablation catheter
US8187268B2 (en) 2004-05-26 2012-05-29 Kimberly-Clark, Inc. Electrosurgical apparatus having a temperature sensor
US20050267555A1 (en) 2004-05-28 2005-12-01 Marnfeldt Goran N Engagement tool for implantable medical devices
EP1758518A2 (en) 2004-06-07 2007-03-07 Edwards Lifesciences Corporation Methods and devices for directionally ablating tissue
US8480696B2 (en) 2004-06-16 2013-07-09 Medtronic, Inc. Minimally invasive coring vein harvester
US20060004317A1 (en) 2004-06-30 2006-01-05 Christophe Mauge Hydrocephalus shunt
US20070198019A1 (en) 2004-07-29 2007-08-23 X-Sten Corp. Spinal ligament modification devices
US7875049B2 (en) 2004-10-04 2011-01-25 Medtronic, Inc. Expandable guide sheath with steerable backbone and methods for making and using them
US7993350B2 (en) 2004-10-04 2011-08-09 Medtronic, Inc. Shapeable or steerable guide sheaths and methods for making and using them
WO2006050087A2 (en) 2004-10-29 2006-05-11 Depuy Products, Inc. Coordinate instrument set
US8043297B2 (en) 2004-11-03 2011-10-25 Synthes Usa, Llc Aiming arm for bone plates
DE602005026983D1 (en) 2004-11-29 2011-04-28 Granit Medical Innovations Llc TURNING FINE NEEDLE FOR TAKING TISSUE BIOPSY SAMPLES
US20060229550A1 (en) * 2004-12-14 2006-10-12 Hydrocision, Incorporated Liquid jet surgical instrument
US7611474B2 (en) 2004-12-29 2009-11-03 Ethicon Endo-Surgery, Inc. Core sampling biopsy device with short coupled MRI-compatible driver
US7462167B2 (en) 2005-01-26 2008-12-09 Thomas Medical Products, Inc. Catheter sheath slitter and method of use
US7510524B2 (en) 2005-04-04 2009-03-31 Invuity, Inc. Optical waveguide sheath
US10653440B2 (en) 2005-04-15 2020-05-19 Cook Medical Technologies Llc Tip for lead extraction device
KR101299084B1 (en) 2005-04-15 2013-08-27 쿡 배스큘러 인코포레이티드 Lead Extraction Device
US7974710B2 (en) 2005-04-28 2011-07-05 Medtronic, Inc. Guide catheters for accessing cardiac sites
WO2006119166A2 (en) 2005-04-29 2006-11-09 The Regents Of The University Of Colorado Multi-excitation diagnostic systems and methods for classification of tissue
WO2006122061A1 (en) 2005-05-06 2006-11-16 Acumen Medical, Inc. Complexly shaped steerable catheters and methods for making and using them
US8834492B2 (en) 2005-05-20 2014-09-16 Neotract, Inc. Continuous indentation lateral lobe apparatus and method
US8945152B2 (en) 2005-05-20 2015-02-03 Neotract, Inc. Multi-actuating trigger anchor delivery system
US7758594B2 (en) 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US7909836B2 (en) 2005-05-20 2011-03-22 Neotract, Inc. Multi-actuating trigger anchor delivery system
US8529584B2 (en) 2005-05-20 2013-09-10 Neotract, Inc. Median lobe band implant apparatus and method
US8668705B2 (en) 2005-05-20 2014-03-11 Neotract, Inc. Latching anchor device
US8425535B2 (en) 2005-05-20 2013-04-23 Neotract, Inc. Multi-actuating trigger anchor delivery system
US8603106B2 (en) 2005-05-20 2013-12-10 Neotract, Inc. Integrated handle assembly for anchor delivery system
US8628542B2 (en) 2005-05-20 2014-01-14 Neotract, Inc. Median lobe destruction apparatus and method
US8157815B2 (en) 2005-05-20 2012-04-17 Neotract, Inc. Integrated handle assembly for anchor delivery system
US9149266B2 (en) 2005-05-20 2015-10-06 Neotract, Inc. Deforming anchor device
US8394113B2 (en) 2005-05-20 2013-03-12 Neotract, Inc. Coiled anchor device
US8491606B2 (en) 2005-05-20 2013-07-23 Neotract, Inc. Median lobe retraction apparatus and method
US7645286B2 (en) 2005-05-20 2010-01-12 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US8333776B2 (en) 2005-05-20 2012-12-18 Neotract, Inc. Anchor delivery system
US7896891B2 (en) 2005-05-20 2011-03-01 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US8097012B2 (en) 2005-07-27 2012-01-17 The Spectranetics Corporation Endocardial lead removing apparatus
US7993359B1 (en) 2005-07-27 2011-08-09 The Spectrametics Corporation Endocardial lead removing apparatus
US8239039B2 (en) 2005-08-30 2012-08-07 Cardiac Pacemakers, Inc. Device on lead to prevent perforation and/or fixate lead
US20070078500A1 (en) 2005-09-30 2007-04-05 Cornova, Inc. Systems and methods for analysis and treatment of a body lumen
US7328071B1 (en) 2005-10-12 2008-02-05 Pacesetter, Inc. Lead placement device
US7651503B1 (en) 2005-10-26 2010-01-26 The Spectranetics Corporation Endocardial lead cutting apparatus
US8007488B2 (en) 2005-11-10 2011-08-30 Phase One Medical Llc Catheter device
JP2009515598A (en) 2005-11-10 2009-04-16 フェイズ ワン メディカル リミテッド ライアビリティ カンパニー Catheter device
US8235916B2 (en) 2006-02-03 2012-08-07 Pacesetter, Inc. System and method for manipulating insertion pathways for accessing target sites
US20110022057A1 (en) 2006-02-03 2011-01-27 Pacesetter, Inc. Apparatus and methods for transferring an implanted elongate body to a remote site
US8372098B2 (en) 2006-02-08 2013-02-12 Merit Medical Systems, Inc. Fluid line removal device for removing a fluid line from a body and related methods
US8128636B2 (en) 2006-02-13 2012-03-06 Cook Medical Technologies Llc Device and method for removing lumenless leads
US7942830B2 (en) 2006-05-09 2011-05-17 Vertos Medical, Inc. Ipsilateral approach to minimally invasive ligament decompression procedure
US20090221994A1 (en) 2006-05-11 2009-09-03 Wolfgang Neuberger Device and Method for Improved Vascular Laser Treatment
WO2007147058A2 (en) * 2006-06-14 2007-12-21 Cornova, Inc. Method and apparatus for identifying and treating myocardial infarction
CN102327139A (en) 2006-06-30 2012-01-25 阿瑟罗迈德公司 Atherectomy device
US20080004645A1 (en) 2006-06-30 2008-01-03 Atheromed, Inc. Atherectomy devices and methods
US8361094B2 (en) 2006-06-30 2013-01-29 Atheromed, Inc. Atherectomy devices and methods
US20080045986A1 (en) 2006-06-30 2008-02-21 Atheromed, Inc. Atherectomy devices and methods
US8007506B2 (en) 2006-06-30 2011-08-30 Atheromed, Inc. Atherectomy devices and methods
US20110112563A1 (en) 2006-06-30 2011-05-12 Atheromed, Inc. Atherectomy devices and methods
US20090018566A1 (en) 2006-06-30 2009-01-15 Artheromed, Inc. Atherectomy devices, systems, and methods
US8666479B2 (en) * 2006-07-10 2014-03-04 Boston Scientific Scimed, Inc. Optical spectroscopic injection needle
US20080097378A1 (en) 2006-08-02 2008-04-24 Zuckerman Stephen D Optical device for needle placement into a joint
US8636715B2 (en) 2006-09-25 2014-01-28 Medtronic Vascular, Inc. High torque, low profile catheters and methods for transluminal interventions
EP2068730B1 (en) 2006-10-04 2016-11-23 Boston Scientific Limited Interventional catheters
US8394078B2 (en) 2006-10-04 2013-03-12 Medrad, Inc. Interventional catheters incorporating an active aspiration system
AU2007333079A1 (en) 2006-12-12 2008-06-19 Curve Medical Llc Laser energy device for soft tissue removal
US7938786B2 (en) 2006-12-13 2011-05-10 Devicor Medical Products, Inc. Vacuum timing algorithm for biopsy device
US7981049B2 (en) 2006-12-13 2011-07-19 Devicor Medical Products, Inc. Engagement interface for biopsy system vacuum module
US8251916B2 (en) 2006-12-13 2012-08-28 Devicor Medical Products, Inc. Revolving tissue sample holder for biopsy device
US8192430B2 (en) 2006-12-15 2012-06-05 Cook Medical Technologies Llc Device for extracting an elongated structure implanted in biological tissue
US7801624B1 (en) * 2007-01-16 2010-09-21 Pacesetter, Inc. Reduced perforation distal tip for an implantable cardiac electrotherapy lead
US9144462B2 (en) 2007-01-30 2015-09-29 Merit Medical Systems, Inc. Introducer sheath and hub assembly
EP1967152B1 (en) 2007-03-05 2010-12-08 Amj B.V. Device for creating openings in pressurized blood vessels
US8202268B1 (en) 2007-03-18 2012-06-19 Lockheed Martin Corporation Method and multiple-mode device for high-power short-pulse laser ablation and CW cauterization of bodily tissues
US9254144B2 (en) * 2007-03-30 2016-02-09 Covidien Lp Methods and apparatus for thrombectomy system
US7720362B2 (en) 2007-04-24 2010-05-18 Arizant Healthcare Inc. Heat exchanger for high flow rate infusion
US20080281308A1 (en) 2007-05-07 2008-11-13 Ceramoptec Industries, Inc. Device and method for improved vascular laser treatment
WO2008141238A1 (en) 2007-05-11 2008-11-20 Voyage Medical, Inc. Visual electrode ablation systems
US7976551B1 (en) 2007-06-14 2011-07-12 Pacesetter, Inc. Transseptal delivery instrument
AU2008271034A1 (en) 2007-06-29 2009-01-08 Atheromed, Inc. Atherectomy devices, systems, and methods
US8758366B2 (en) 2007-07-09 2014-06-24 Neotract, Inc. Multi-actuating trigger anchor delivery system
US8343167B2 (en) 2007-08-06 2013-01-01 Reverse Medical Corporation Thrombectomy system and method
US20090216322A1 (en) 2007-08-10 2009-08-27 Le Le Adjustable annuloplasty ring and activation system
EP2039390B1 (en) 2007-09-18 2010-11-10 Ela Medical Tool for cutting the tubular sheath of a catheter-guide in the presence of a probe lodged in this sheath
US8142446B2 (en) 2007-09-18 2012-03-27 Sorin Crm S.A.S. Toolkit for implanting an intracorporeal lead such as for cardiac pacing or sensing
AU2008302039B2 (en) 2007-09-21 2013-07-18 Covidien Lp Surgical device
EP3097869B1 (en) 2007-09-21 2020-03-11 Covidien LP Surgical device
US9283034B2 (en) 2007-09-26 2016-03-15 Retrovascular, Inc. Recanalization system using radiofrequency energy
US8202229B2 (en) 2007-10-01 2012-06-19 Suros Surgical Systems, Inc. Surgical device
US8224417B2 (en) 2007-10-17 2012-07-17 Neuronexus Technologies, Inc. Guide tube for an implantable device system
WO2009054968A1 (en) 2007-10-22 2009-04-30 Atheromed, Inc. Atherectomy devices and methods
US8070762B2 (en) 2007-10-22 2011-12-06 Atheromed Inc. Atherectomy devices and methods
US8236016B2 (en) 2007-10-22 2012-08-07 Atheromed, Inc. Atherectomy devices and methods
WO2009065078A1 (en) 2007-11-14 2009-05-22 Pathway Medical Technologies, Inc. Delivery and administration of compositions using interventional catheters
WO2009065082A1 (en) 2007-11-14 2009-05-22 Pathway Medical Technologies, Inc. Methods and systems for biological sample collection and analysis
US7858038B2 (en) 2007-11-20 2010-12-28 Devicor Medical Products, Inc. Biopsy device with illuminated tissue holder
US8052616B2 (en) 2007-11-20 2011-11-08 Devicor Medical Products, Inc. Biopsy device with fine pitch drive train
US7798813B1 (en) 2007-11-20 2010-09-21 Harrel Stephen K Rotary tissue removing instrument
US7806835B2 (en) 2007-11-20 2010-10-05 Devicor Medical Products, Inc. Biopsy device with sharps reduction feature
US9402643B2 (en) 2008-01-15 2016-08-02 Novartis Ag Targeted illumination for surgical instrument
US20090198098A1 (en) 2008-02-01 2009-08-06 Olympus Medical Systems Corp. Endoscope treatment instrument
EP2254497A1 (en) 2008-02-21 2010-12-01 Amj B.V. Laser catheter for bypass surgery and assembly comprising said catheter
CN102088920B (en) 2008-04-10 2013-04-24 阿瑟罗迈德公司 Atherectomy devices
US20100125253A1 (en) 2008-11-17 2010-05-20 Avinger Dual-tip Catheter System for Boring through Blocked Vascular Passages
WO2009141822A1 (en) 2008-05-21 2009-11-26 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center A device and method for crossing occlusions
US8126571B2 (en) * 2008-06-23 2012-02-28 Cardiac Pacemakers, Inc. Expandable assembly for cardiac lead fixation
EP2328524B1 (en) 2008-07-02 2019-01-16 Cook Medical Technologies LLC Deployment assembly
US8257312B2 (en) 2008-07-30 2012-09-04 Medtronic, Inc. Integrated slitter for medical instrument inserter
US8007469B2 (en) 2008-07-30 2011-08-30 Medtronic, Inc. Medical instrument inserter
WO2010014825A1 (en) 2008-07-30 2010-02-04 Neotract, Inc. Slotted anchor device
EP2345374B1 (en) 2008-07-30 2020-05-20 Neotract, Inc. Anchor delivery system with replaceable cartridge
US8882751B2 (en) 2008-09-09 2014-11-11 Cook Medical Technologies Llc Wire guided thrombectomy device
CA2739326A1 (en) 2008-10-10 2010-04-15 Intervalve, Inc. Valvuloplasty catheter and methods
USD619253S1 (en) 2008-10-23 2010-07-06 Vertos Medical, Inc. Tissue modification device
USD635671S1 (en) 2008-10-23 2011-04-05 Vertos Medical, Inc. Tissue modification device
USD619252S1 (en) 2008-10-23 2010-07-06 Vertos Medical, Inc. Tissue modification device
USD611146S1 (en) 2008-10-23 2010-03-02 Vertos Medical, Inc. Tissue modification device
USD621939S1 (en) 2008-10-23 2010-08-17 Vertos Medical, Inc. Tissue modification device
USD610259S1 (en) 2008-10-23 2010-02-16 Vertos Medical, Inc. Tissue modification device
JP5531352B2 (en) 2008-10-31 2014-06-25 キャスリックス リミテッド Catheter assembly
US9693825B2 (en) * 2008-12-14 2017-07-04 C Laser, Inc. Fiber embedded hollow needle for percutaneous delivery of laser energy
WO2010082139A1 (en) 2009-01-13 2010-07-22 Leadex Cardiac Ltd. Lead extraction methods and apparatus
US8585950B2 (en) 2009-01-29 2013-11-19 Angiodynamics, Inc. Multilumen catheters and method of manufacturing
WO2010091368A1 (en) 2009-02-09 2010-08-12 Spine View, Inc. Helical groove dilating device and related methods
USD600792S1 (en) 2009-02-12 2009-09-22 Pathway Medical Technologies, Inc. Tubing cassette
US8747417B2 (en) 2009-02-25 2014-06-10 Pacesetter, Inc. Device and method for the implantation of active fixation medical leads
US20100222787A1 (en) 2009-03-02 2010-09-02 Cook Vascular Incorporated Tension control device
US8326437B2 (en) 2009-03-04 2012-12-04 W. L. Gore & Associates, Inc. Atraumatic lead removal sheath
JP5489187B2 (en) 2009-04-03 2014-05-14 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティー Surgical apparatus and method
US9364259B2 (en) 2009-04-21 2016-06-14 Xlumena, Inc. System and method for delivering expanding trocar through a sheath
US8333740B2 (en) 2009-05-01 2012-12-18 Shippert Ronald D Tissue transfer cannula
US9566082B2 (en) 2009-05-22 2017-02-14 Slatr Surgical Holdings Llc Endoscopic instrument
EP2449452B1 (en) 2009-07-03 2016-02-10 Tactus Technology User interface enhancement system
US8938310B2 (en) 2009-07-07 2015-01-20 The Trustees Of Columbia University In The City Of New York Coronary sinus cannula with left ventricle lead and pressure tent
US20110028959A1 (en) 2009-07-30 2011-02-03 Paul Chasan Surgical Apparatus and Method for Performing Minimally Invasive Surgery
US8388582B2 (en) 2009-08-12 2013-03-05 Medrad, Inc. Systems and methods for operating interventional catheters using a common operating console and adaptive interface components
US8435228B2 (en) 2009-08-12 2013-05-07 Medrad, Inc. Interventional catheter assemblies incorporating guide wire brake and management systems
US9072540B2 (en) 2009-08-12 2015-07-07 Boston Scientific Limited Adaptive tubing cassettes for use in connection with interventional catheter assemblies
EP2473123B1 (en) * 2009-09-03 2019-01-30 Boston Scientific Limited Lancet micro-catheter
US20120265183A1 (en) 2009-09-11 2012-10-18 Amj Bv Catheter system for bypass surgery and a method for preparing a catheter system for bypass surgery
US20110106099A1 (en) 2009-10-29 2011-05-05 Medtronic, Inc. Lead extraction device
EP2493390B1 (en) 2009-10-30 2014-12-31 Cook Medical Technologies LLC System for performing a full thickness tissue biopsy
EP2496151A2 (en) 2009-11-06 2012-09-12 Innerpulse Methods and systems for removal of implantable intravascular devices
WO2011084863A2 (en) 2010-01-07 2011-07-14 Cheetah Omni, Llc Fiber lasers and mid-infrared light sources in methods and systems for selective biological tissue processing and spectroscopy
EP2525864A4 (en) 2010-01-20 2014-03-05 Pavilion Medical Innovations Llc Systems and methods for removal of intravascular leads
US20110218528A1 (en) 2010-03-05 2011-09-08 Retro Vascular, Inc. Anatomical structure access and penetration
WO2011123342A1 (en) 2010-03-29 2011-10-06 Cook Medical Technologies Llc Device and method for positioning an implanted structure to facilitate removal
CN103002826B (en) 2010-04-22 2016-11-09 精密光手术公司 Flash distillation surgery systems
US9067042B2 (en) 2010-04-30 2015-06-30 Medtronic, Inc. Steerable stylet with guidewire tip
US20110270170A1 (en) 2010-04-30 2011-11-03 Medtronic, Inc. Steerable Medical Device Having Means For Imparting Multiple Curves in the Device
WO2011162595A1 (en) 2010-06-24 2011-12-29 Vascular Connect B.V. Laser catheter for bypass surgery
US9239049B2 (en) 2010-07-16 2016-01-19 Boston Scientific Limited Peristaltic pump having a self-closing occlusion bed
JP2013537835A (en) 2010-09-28 2013-10-07 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ Devices and methods for positioning electrodes in tissue
US8845621B2 (en) 2010-10-19 2014-09-30 Distal Access, Llc Apparatus for rotating medical devices, systems including the apparatus, and associated methods
US9107691B2 (en) 2010-10-19 2015-08-18 Distal Access, Llc Apparatus for rotating medical devices, systems including the apparatus, and associated methods
EP2637591B1 (en) 2010-11-12 2019-07-17 Estech, Inc (Endoscopic Technologies, Inc) Stabilized ablation systems
WO2012082755A1 (en) 2010-12-13 2012-06-21 Nanostim, Inc. Pacemaker retrieval systems and methods
JP5696484B2 (en) * 2011-01-12 2015-04-08 セイコーエプソン株式会社 Fluid ejection device, medical equipment
FR2970654B1 (en) 2011-01-20 2014-03-14 Raymond A & Cie DEVICE FOR INTRODUCING ELEMENTS INTO A BODY
BR112013021463A2 (en) * 2011-02-24 2016-11-01 Eximo Medical Ltd tissue resection hybrid catheter
US8900161B2 (en) 2011-04-01 2014-12-02 Cook Medical Technologies Llc Tissue sampling device and method
US8512326B2 (en) 2011-06-24 2013-08-20 Arqos Surgical, Inc. Tissue extraction devices and methods
US9649490B2 (en) 2011-06-16 2017-05-16 Cook Medical Technologies Llc Tip for lead extraction device
JP5681864B2 (en) 2011-06-21 2015-03-11 コルファスコ メディカル ベスローテン フェンノートシャップCorvasco Medical B.V. Laser catheter for bypass surgery and assembly including such a catheter
US20130031800A1 (en) * 2011-08-02 2013-02-07 Su-Fang Ou Shoe Vamp
US8821527B2 (en) 2011-09-07 2014-09-02 Circulite, Inc. Cannula tips, tissue attachment rings, and methods of delivering and using the same
CA2850495A1 (en) 2011-10-03 2013-04-11 Biolase, Inc. Surgical laser cutting device
US8945146B2 (en) 2011-10-24 2015-02-03 Medtronic, Inc. Delivery system assemblies and associated methods for implantable medical devices
US9949753B2 (en) 2012-09-14 2018-04-24 The Spectranetics Corporation Tissue slitting methods and systems
US11000333B2 (en) 2013-03-13 2021-05-11 The Spectranetics Corporation Angular optical fiber catheter
US10383691B2 (en) 2013-03-13 2019-08-20 The Spectranetics Corporation Last catheter with helical internal lumen
US9456872B2 (en) 2013-03-13 2016-10-04 The Spectranetics Corporation Laser ablation catheter
US9283040B2 (en) 2013-03-13 2016-03-15 The Spectranetics Corporation Device and method of ablative cutting with helical tip
US9883885B2 (en) 2013-03-13 2018-02-06 The Spectranetics Corporation System and method of ablative cutting and pulsed vacuum aspiration
US9623211B2 (en) 2013-03-13 2017-04-18 The Spectranetics Corporation Catheter movement control
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
US20140276696A1 (en) * 2013-03-14 2014-09-18 The Spectranetics Corporation Threaded lead extraction device
US9668765B2 (en) 2013-03-15 2017-06-06 The Spectranetics Corporation Retractable blade for lead removal device

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228052B1 (en) * 1996-02-29 2001-05-08 Medtronic Inc. Dilator for introducer system having injection port
US6419674B1 (en) * 1996-11-27 2002-07-16 Cook Vascular Incorporated Radio frequency dilator sheath
US20080154293A1 (en) * 2006-12-22 2008-06-26 The Spectranetics Corporation Retractable Separating Systems and Methods
US20080154296A1 (en) * 2006-12-22 2008-06-26 The Spectranetics Corporation Tissue Separating Systems and Methods

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10368900B2 (en) 2012-09-14 2019-08-06 The Spectranetics Corporation Tissue slitting methods and systems
US10835279B2 (en) 2013-03-14 2020-11-17 Spectranetics Llc Distal end supported tissue slitting apparatus
US11925380B2 (en) 2013-03-14 2024-03-12 Spectranetics Llc Distal end supported tissue slitting apparatus
WO2017217998A1 (en) * 2016-06-16 2017-12-21 Datta Subhajit Dual vacuum device for medical fixture placement including thoracoscopic left ventricular lead placement
US10933247B2 (en) 2017-08-21 2021-03-02 MRM MedTech, LLC Lead with integrated features to facilitate extraction and associated methods of extraction
US11865334B2 (en) 2017-08-21 2024-01-09 MRM MedTech, LLC Lead with integrated feature including a low friction component to facilitate extraction and associated methods of extraction

Also Published As

Publication number Publication date
US20140081367A1 (en) 2014-03-20
EP2895087A1 (en) 2015-07-22
US11596435B2 (en) 2023-03-07
US20140081304A1 (en) 2014-03-20
US20180214175A1 (en) 2018-08-02
US9949753B2 (en) 2018-04-24
US20230181215A1 (en) 2023-06-15
EP2895078A1 (en) 2015-07-22
US9413896B2 (en) 2016-08-09
US20160338727A1 (en) 2016-11-24
US20140081303A1 (en) 2014-03-20
EP2895087B1 (en) 2017-10-25
US9763692B2 (en) 2017-09-19
WO2014043329A1 (en) 2014-03-20
US20140081306A1 (en) 2014-03-20
US9724122B2 (en) 2017-08-08
US10368900B2 (en) 2019-08-06
US20170325835A1 (en) 2017-11-16
US10531891B2 (en) 2020-01-14
US20140081289A1 (en) 2014-03-20
US20170340346A1 (en) 2017-11-30
EP3284420A1 (en) 2018-02-21
US20200107854A1 (en) 2020-04-09
EP2895078A4 (en) 2016-06-08
WO2014043337A1 (en) 2014-03-20
US20140081252A1 (en) 2014-03-20
EP2895087A4 (en) 2016-05-11

Similar Documents

Publication Publication Date Title
US20160022303A1 (en) Lead removal sleeve
US20210307776A1 (en) Multiple configuration surgical cutting device
US10314615B2 (en) Medical device for removing an implanted object
US10080888B2 (en) Interventional medical systems and associated methods
US11925380B2 (en) Distal end supported tissue slitting apparatus
US10143457B2 (en) Fistula plugs having increased column strength and fistula plug delivery apparatuses and methods
US10542964B2 (en) Interventional medical device retrieval
US20110106099A1 (en) Lead extraction device
US20140276696A1 (en) Threaded lead extraction device
US10894162B2 (en) Delivery devices and methods for leadless cardiac devices
US20050192591A1 (en) Device for removing an elongated structure implanted in biological tissue
US10434306B2 (en) Enhanced outer sheath for extraction device
EP3554607B1 (en) Medical probe
US8092467B1 (en) Apparatus and method facilitating removal of a structure implanted in a body
US20220218502A1 (en) Pulmonary Arterial Compliance Enhancement Device
EP3863534B1 (en) Medical device retrieval tool with adjustable curve

Legal Events

Date Code Title Description
AS Assignment

Owner name: MIDCAP FINANCIAL TRUST, AS AGENT, MARYLAND

Free format text: SECURITY INTEREST (TERM);ASSIGNOR:THE SPECTRANETICS CORPORATION;REEL/FRAME:037269/0506

Effective date: 20151207

Owner name: MIDCAP FINANCIAL TRUST, AS AGENT, MARYLAND

Free format text: SECURITY INTEREST (REVOLVER);ASSIGNOR:THE SPECTRANETICS CORPORATION;REEL/FRAME:037269/0425

Effective date: 20151207

AS Assignment

Owner name: THE SPECTRANETICS CORPORATION, COLORADO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FISER, RICHARD LOFTON;REEL/FRAME:039469/0435

Effective date: 20130411

AS Assignment

Owner name: ANGIOSCORE INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FINANCIAL TRUST;REEL/FRAME:043518/0066

Effective date: 20170809

Owner name: THE SPECTRANETICS CORPORATION, COLORADO

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FINANCIAL TRUST;REEL/FRAME:043518/0066

Effective date: 20170809

Owner name: THE SPECTRANETICS CORPORATION, COLORADO

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FINANCIAL TRUST;REEL/FRAME:043518/0142

Effective date: 20170809

Owner name: ANGIOSCORE INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:MIDCAP FINANCIAL TRUST;REEL/FRAME:043518/0142

Effective date: 20170809

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION